HRP20010059A2 - Isoquinolines as urokinase inhibitors - Google Patents
Isoquinolines as urokinase inhibitors Download PDFInfo
- Publication number
- HRP20010059A2 HRP20010059A2 HR20010059A HRP20010059A HRP20010059A2 HR P20010059 A2 HRP20010059 A2 HR P20010059A2 HR 20010059 A HR20010059 A HR 20010059A HR P20010059 A HRP20010059 A HR P20010059A HR P20010059 A2 HRP20010059 A2 HR P20010059A2
- Authority
- HR
- Croatia
- Prior art keywords
- isoquinolinyl
- guanidino
- mmol
- chloro
- sulfonyl
- Prior art date
Links
- 239000002797 plasminogen activator inhibitor Substances 0.000 title description 8
- 150000002537 isoquinolines Chemical class 0.000 title description 3
- -1 het Chemical group 0.000 claims description 238
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 134
- 150000001875 compounds Chemical class 0.000 claims description 107
- 150000003839 salts Chemical class 0.000 claims description 85
- 238000002360 preparation method Methods 0.000 claims description 82
- 229910052757 nitrogen Inorganic materials 0.000 claims description 80
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 67
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 64
- 239000000460 chlorine Substances 0.000 claims description 58
- 229920006395 saturated elastomer Polymers 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 43
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 34
- 125000001424 substituent group Chemical group 0.000 claims description 31
- ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 28
- 238000006243 chemical reaction Methods 0.000 claims description 28
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 28
- 125000003118 aryl group Chemical group 0.000 claims description 27
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 claims description 22
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 21
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 125000005843 halogen group Chemical group 0.000 claims description 19
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 19
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical group C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 claims description 18
- 229910052760 oxygen Inorganic materials 0.000 claims description 16
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 14
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 14
- 229910052801 chlorine Inorganic materials 0.000 claims description 13
- OSILBMSORKFRTB-UHFFFAOYSA-N isoquinolin-1-amine Chemical class C1=CC=C2C(N)=NC=CC2=C1 OSILBMSORKFRTB-UHFFFAOYSA-N 0.000 claims description 13
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 12
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 12
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 12
- 125000002947 alkylene group Chemical group 0.000 claims description 12
- 229910052794 bromium Chemical group 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 12
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 11
- CXDHJGCWMIOAQP-UHFFFAOYSA-N 2-pyridin-3-yl-1,4,5,6-tetrahydropyrimidine;hydrochloride Chemical compound Cl.C1CCNC(C=2C=NC=CC=2)=N1 CXDHJGCWMIOAQP-UHFFFAOYSA-N 0.000 claims description 10
- IPZJQDSFZGZEOY-UHFFFAOYSA-N dimethylmethylene Chemical group C[C]C IPZJQDSFZGZEOY-UHFFFAOYSA-N 0.000 claims description 10
- 125000003545 alkoxy group Chemical group 0.000 claims description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 125000005842 heteroatom Chemical group 0.000 claims description 8
- 229910052717 sulfur Inorganic materials 0.000 claims description 8
- FKLXTEJVWZKEGC-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclopentane-1-carboxylic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(O)=O)CCCC1 FKLXTEJVWZKEGC-UHFFFAOYSA-N 0.000 claims description 7
- MWEYSFQTTAFUFL-GFCCVEGCSA-N (2r)-1-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylpyrrolidine-2-carboxylic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N1CCC[C@@H]1C(O)=O MWEYSFQTTAFUFL-GFCCVEGCSA-N 0.000 claims description 6
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 6
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 6
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 230000001404 mediated effect Effects 0.000 claims description 6
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 5
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 5
- 239000005977 Ethylene Substances 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 5
- LNUBQTYRTKJZLL-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[2-(oxan-2-yloxy)ethyl]amino]cyclopentane-1-carboxylic acid Chemical class C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(C1(CCCC1)C(O)=O)CCOC1CCCCO1 LNUBQTYRTKJZLL-UHFFFAOYSA-N 0.000 claims description 4
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 claims description 4
- 125000000732 arylene group Chemical group 0.000 claims description 4
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 4
- 125000001072 heteroaryl group Chemical group 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 4
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 4
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 4
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 4
- 125000003386 piperidinyl group Chemical group 0.000 claims description 4
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical group CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 claims description 3
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 3
- 150000001409 amidines Chemical class 0.000 claims description 3
- 239000002585 base Substances 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 3
- 125000006513 pyridinyl methyl group Chemical group 0.000 claims description 3
- BMEATRFQZUKHQA-MRXNPFEDSA-N tert-butyl (2r)-1-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylpiperidine-2-carboxylate Chemical compound CC(C)(C)OC(=O)[C@H]1CCCCN1S(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 BMEATRFQZUKHQA-MRXNPFEDSA-N 0.000 claims description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims description 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 2
- BRGLJXKRORUYFU-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-n-(2-methoxyethyl)cyclopentane-1-carboxamide Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)NCCOC)CCCC1 BRGLJXKRORUYFU-UHFFFAOYSA-N 0.000 claims description 2
- WGQAIRAOZLFUSH-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclohexane-1-carboxylic acid Chemical class C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(O)=O)CCCCC1 WGQAIRAOZLFUSH-UHFFFAOYSA-N 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 2
- 125000004976 cyclobutylene group Chemical group 0.000 claims description 2
- 125000004977 cycloheptylene group Chemical group 0.000 claims description 2
- 125000004956 cyclohexylene group Chemical group 0.000 claims description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000004979 cyclopentylene group Chemical group 0.000 claims description 2
- 239000012458 free base Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000004187 tetrahydropyran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 101100133350 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) nhp-1 gene Proteins 0.000 claims 2
- 229910052698 phosphorus Inorganic materials 0.000 claims 2
- SFSCYVUZGPRXIE-CYBMUJFWSA-N (2r)-1-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylpiperidine-2-carboxylic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N1CCCC[C@@H]1C(O)=O SFSCYVUZGPRXIE-CYBMUJFWSA-N 0.000 claims 1
- OXLQLJKXSBVAFG-UHFFFAOYSA-N 1-[[4-bromo-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[2-(dimethylamino)ethyl]amino]cyclopentane-1-carboxylic acid Chemical compound C=1C=C2C(Br)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)N(CCN(C)C)C1(C(O)=O)CCCC1 OXLQLJKXSBVAFG-UHFFFAOYSA-N 0.000 claims 1
- LIPQMUVUZWSFOR-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[2-(dimethylamino)ethyl]amino]cyclopentane-1-carboxylic acid Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)N(CCN(C)C)C1(C(O)=O)CCCC1 LIPQMUVUZWSFOR-UHFFFAOYSA-N 0.000 claims 1
- OGLMCCZSIWUXDA-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-n-(2-hydroxyethyl)-n-methylcyclopentane-1-carboxamide Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)N(CCO)C)CCCC1 OGLMCCZSIWUXDA-UHFFFAOYSA-N 0.000 claims 1
- DEPFCMSTRPLWNG-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclobutane-1-carboxylic acid Chemical class C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(O)=O)CCC1 DEPFCMSTRPLWNG-UHFFFAOYSA-N 0.000 claims 1
- UGFABUVNULNZNU-UHFFFAOYSA-N 2-[4-chloro-7-[[1-(morpholine-4-carbonyl)cyclopentyl]sulfamoyl]isoquinolin-1-yl]guanidine Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(=O)N2CCOCC2)CCCC1 UGFABUVNULNZNU-UHFFFAOYSA-N 0.000 claims 1
- XSDAXWRCPTYNOD-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-2-methylpropanoic acid Chemical compound ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)NC(C)(C)C(O)=O)=CC=C21 XSDAXWRCPTYNOD-UHFFFAOYSA-N 0.000 claims 1
- ZHHDLYHTFLCWAS-UHFFFAOYSA-N 4-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]oxane-4-carboxylic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(O)=O)CCOCC1 ZHHDLYHTFLCWAS-UHFFFAOYSA-N 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 409
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 340
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 335
- 239000000243 solution Substances 0.000 description 307
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 225
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 221
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 207
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 172
- 239000007787 solid Substances 0.000 description 171
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 168
- 235000019439 ethyl acetate Nutrition 0.000 description 168
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 138
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 122
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 121
- 239000003480 eluent Substances 0.000 description 114
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 110
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 105
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 100
- 238000010898 silica gel chromatography Methods 0.000 description 99
- 239000002904 solvent Substances 0.000 description 93
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 84
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 80
- 229960000789 guanidine hydrochloride Drugs 0.000 description 79
- 239000012267 brine Substances 0.000 description 78
- 229910000104 sodium hydride Inorganic materials 0.000 description 78
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 77
- 239000006185 dispersion Substances 0.000 description 72
- 239000002480 mineral oil Substances 0.000 description 71
- 235000010446 mineral oil Nutrition 0.000 description 71
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 65
- 239000002244 precipitate Substances 0.000 description 63
- 239000000284 extract Substances 0.000 description 60
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 60
- 239000000725 suspension Substances 0.000 description 55
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 53
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 53
- 239000011541 reaction mixture Substances 0.000 description 52
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 51
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 51
- 235000002639 sodium chloride Nutrition 0.000 description 51
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 50
- 235000019341 magnesium sulphate Nutrition 0.000 description 50
- UVTOICZCRRXFKE-UHFFFAOYSA-N 1,4-dichloroisoquinoline-7-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=C2C(Cl)=CN=C(Cl)C2=C1 UVTOICZCRRXFKE-UHFFFAOYSA-N 0.000 description 49
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 46
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 40
- 238000001914 filtration Methods 0.000 description 37
- QVDYYQXUNAQSNI-UHFFFAOYSA-N ethyl acetate;pentane Chemical compound CCCCC.CCOC(C)=O QVDYYQXUNAQSNI-UHFFFAOYSA-N 0.000 description 32
- 239000000843 powder Substances 0.000 description 32
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 29
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 27
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 26
- 235000017557 sodium bicarbonate Nutrition 0.000 description 26
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 26
- DTQVDTLACAAQTR-DYCDLGHISA-N trifluoroacetic acid-d1 Chemical compound [2H]OC(=O)C(F)(F)F DTQVDTLACAAQTR-DYCDLGHISA-N 0.000 description 26
- 238000010992 reflux Methods 0.000 description 25
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 23
- 239000000741 silica gel Substances 0.000 description 23
- 229910002027 silica gel Inorganic materials 0.000 description 23
- 239000006260 foam Substances 0.000 description 20
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 20
- 238000004587 chromatography analysis Methods 0.000 description 18
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 239000000126 substance Substances 0.000 description 18
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- 239000012074 organic phase Substances 0.000 description 16
- SJMDMGHPMLKLHQ-UHFFFAOYSA-N tert-butyl 2-aminoacetate Chemical compound CC(C)(C)OC(=O)CN SJMDMGHPMLKLHQ-UHFFFAOYSA-N 0.000 description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 239000006196 drop Substances 0.000 description 14
- 229940012957 plasmin Drugs 0.000 description 14
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 238000001665 trituration Methods 0.000 description 13
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 12
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 229960005356 urokinase Drugs 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 238000001556 precipitation Methods 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 10
- 239000003513 alkali Substances 0.000 description 10
- 238000002425 crystallisation Methods 0.000 description 10
- 230000008025 crystallization Effects 0.000 description 10
- 238000001704 evaporation Methods 0.000 description 10
- 230000008020 evaporation Effects 0.000 description 10
- 229960004198 guanidine Drugs 0.000 description 10
- 229910000027 potassium carbonate Inorganic materials 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 235000015320 potassium carbonate Nutrition 0.000 description 9
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 8
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- ZCCHALYUTAVUSN-UHFFFAOYSA-N 2-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]acetic acid Chemical compound ClC1=CN=C(Cl)C2=CC(S(=O)(=O)NCC(=O)O)=CC=C21 ZCCHALYUTAVUSN-UHFFFAOYSA-N 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 7
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 7
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000012230 colorless oil Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 238000010511 deprotection reaction Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 239000004474 valine Substances 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 6
- 235000019270 ammonium chloride Nutrition 0.000 description 6
- 239000000538 analytical sample Substances 0.000 description 6
- 230000033115 angiogenesis Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 239000012452 mother liquor Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 230000029663 wound healing Effects 0.000 description 6
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 5
- YRRBJVJOEBRPNJ-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[(4-methoxyphenyl)methyl]amino]acetic acid Chemical compound C1=CC(OC)=CC=C1CN(CC(O)=O)S(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 YRRBJVJOEBRPNJ-UHFFFAOYSA-N 0.000 description 5
- SOBOKMKYKONTMQ-UHFFFAOYSA-N 2-[benzyl-[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]acetic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1C(=O)N(CC(O)=O)CC1=CC=CC=C1 SOBOKMKYKONTMQ-UHFFFAOYSA-N 0.000 description 5
- YQZBRWHIONZQHW-UHFFFAOYSA-N 3-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]propanoic acid Chemical compound C1=C(C(=O)NCCC(O)=O)C=C2C(NC(=N)N)=NC=C(Cl)C2=C1 YQZBRWHIONZQHW-UHFFFAOYSA-N 0.000 description 5
- 102000001938 Plasminogen Activators Human genes 0.000 description 5
- 108010001014 Plasminogen Activators Proteins 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 229940127126 plasminogen activator Drugs 0.000 description 5
- 125000006239 protecting group Chemical group 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000007838 tissue remodeling Effects 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- PPAGQIPDYXUSCR-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-n,n-dimethylcyclopentane-1-carboxamide Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)N(C)C)CCCC1 PPAGQIPDYXUSCR-UHFFFAOYSA-N 0.000 description 4
- FOEVXJQCBZWDAH-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclopentane-1-carbonyl chloride Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(Cl)=O)CCCC1 FOEVXJQCBZWDAH-UHFFFAOYSA-N 0.000 description 4
- KCDBAKVYEZZRTJ-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclopentane-1-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(O)=O)CCCC1 KCDBAKVYEZZRTJ-UHFFFAOYSA-N 0.000 description 4
- ZXCUCSAPANYTAE-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-(cyclopentylmethyl)amino]acetic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1CCCC1 ZXCUCSAPANYTAE-UHFFFAOYSA-N 0.000 description 4
- OBEVLDNMRHPDRP-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[(3-methoxyphenyl)methyl]amino]acetic acid Chemical compound COC1=CC=CC(CN(CC(O)=O)S(=O)(=O)C=2C=C3C(NC(N)=N)=NC=C(Cl)C3=CC=2)=C1 OBEVLDNMRHPDRP-UHFFFAOYSA-N 0.000 description 4
- NDLXLLJSLDEOHD-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]acetic acid Chemical compound C1=C(S(=O)(=O)NCC(O)=O)C=C2C(NC(=N)N)=NC=C(Cl)C2=C1 NDLXLLJSLDEOHD-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 4
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- 201000004681 Psoriasis Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- OJEYDZBIAYMFFD-UHFFFAOYSA-N cyclopentanecarboxamide Chemical compound NC(=O)C1C[CH]CC1 OJEYDZBIAYMFFD-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 4
- 210000002744 extracellular matrix Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- BHIWKHZACMWKOJ-UHFFFAOYSA-N isobutyric acid methyl ester Natural products COC(=O)C(C)C BHIWKHZACMWKOJ-UHFFFAOYSA-N 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 235000017550 sodium carbonate Nutrition 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- XOXPBLZIYAGQII-OAHLLOKOSA-N (2R)-2-[(1,4-dichloroisoquinoline-7-carbonyl)amino]-2-phenylacetic acid Chemical compound ClC1=NC=C(C2=CC=C(C=C12)C(=O)N[C@H](C1=CC=CC=C1)C(=O)O)Cl XOXPBLZIYAGQII-OAHLLOKOSA-N 0.000 description 3
- HXYHJMSSTIKIBW-UHFFFAOYSA-N 1,4-dichloro-n-[1-(hydroxymethyl)cyclopentyl]isoquinoline-7-sulfonamide Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)NC1(CO)CCCC1 HXYHJMSSTIKIBW-UHFFFAOYSA-N 0.000 description 3
- NYYSTELLMIKOJD-UHFFFAOYSA-N 1,4-dichloroisoquinoline-7-carbonyl chloride Chemical compound ClC1=CN=C(Cl)C2=CC(C(=O)Cl)=CC=C21 NYYSTELLMIKOJD-UHFFFAOYSA-N 0.000 description 3
- JAJNPJRKZCIKSX-UHFFFAOYSA-N 1-[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]pyrrolidine-2-carboxylic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1C(=O)N1CCCC1C(O)=O JAJNPJRKZCIKSX-UHFFFAOYSA-N 0.000 description 3
- DODYLCNGEVXWSK-UHFFFAOYSA-N 1-[[4-bromo-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[2-(dimethylamino)ethyl]amino]cyclopentane-1-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C=1C=C2C(Br)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)N(CCN(C)C)C1(C(O)=O)CCCC1 DODYLCNGEVXWSK-UHFFFAOYSA-N 0.000 description 3
- KVBLKZYVEMXXAR-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[2-(dimethylamino)ethyl]amino]cyclopentane-1-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)N(CCN(C)C)C1(C(O)=O)CCCC1 KVBLKZYVEMXXAR-UHFFFAOYSA-N 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- BPIQTAJUHXPPEI-UHFFFAOYSA-N 2-(n-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylanilino)acetic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)C1=CC=CC=C1 BPIQTAJUHXPPEI-UHFFFAOYSA-N 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- QZUILIMUYMWYNZ-UHFFFAOYSA-N 2-[(1,4-dichloroisoquinoline-7-carbonyl)amino]acetic acid Chemical compound ClC1=CN=C(Cl)C2=CC(C(=O)NCC(=O)O)=CC=C21 QZUILIMUYMWYNZ-UHFFFAOYSA-N 0.000 description 3
- COZYKIRLXOENRO-UHFFFAOYSA-N 2-[(1,4-dichloroisoquinoline-7-carbonyl)amino]butanedioic acid Chemical compound ClC1=CN=C(Cl)C2=CC(C(=O)NC(CC(=O)O)C(O)=O)=CC=C21 COZYKIRLXOENRO-UHFFFAOYSA-N 0.000 description 3
- GZWRFKISPFGGPQ-UHFFFAOYSA-N 2-[(2-methoxyphenyl)methylazaniumyl]acetate Chemical compound COC1=CC=CC=C1CNCC(O)=O GZWRFKISPFGGPQ-UHFFFAOYSA-N 0.000 description 3
- FSHQMEULJGMJPU-UHFFFAOYSA-N 2-[(2-methylphenyl)methylazaniumyl]acetate Chemical compound CC1=CC=CC=C1CNCC(O)=O FSHQMEULJGMJPU-UHFFFAOYSA-N 0.000 description 3
- OGPDDYUQRFSYEJ-UHFFFAOYSA-N 2-[(3-methoxyphenyl)methylazaniumyl]acetate Chemical compound COC1=CC=CC(CNCC(O)=O)=C1 OGPDDYUQRFSYEJ-UHFFFAOYSA-N 0.000 description 3
- LDGLKBHAODXSMN-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]methyl-methylamino]-2-phenylacetic acid Chemical compound C=1C=C2C(Cl)=CN=C(N=C(N)N)C2=CC=1CN(C)C(C(O)=O)C1=CC=CC=C1 LDGLKBHAODXSMN-UHFFFAOYSA-N 0.000 description 3
- DUSOHEUFUBHXJJ-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-(cyclohexylmethyl)amino]acetic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1CCCCC1 DUSOHEUFUBHXJJ-UHFFFAOYSA-N 0.000 description 3
- CZCOGZKCUPMCRK-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-(pyridin-3-ylmethyl)amino]acetic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1=CC=CN=C1 CZCOGZKCUPMCRK-UHFFFAOYSA-N 0.000 description 3
- LKTWTXYOQVQUKL-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-(pyridin-4-ylmethyl)amino]acetic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1=CC=NC=C1 LKTWTXYOQVQUKL-UHFFFAOYSA-N 0.000 description 3
- AQDSGSGLHSNIJL-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[(2-methoxyphenyl)methyl]amino]acetic acid Chemical compound COC1=CC=CC=C1CN(CC(O)=O)S(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 AQDSGSGLHSNIJL-UHFFFAOYSA-N 0.000 description 3
- NKVFMISXWFCPTO-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[(2-methylphenyl)methyl]amino]acetic acid Chemical compound CC1=CC=CC=C1CN(CC(O)=O)S(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 NKVFMISXWFCPTO-UHFFFAOYSA-N 0.000 description 3
- NDVJUKSYUQLKAO-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[(3-chlorophenyl)methyl]amino]acetic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1=CC=CC(Cl)=C1 NDVJUKSYUQLKAO-UHFFFAOYSA-N 0.000 description 3
- JHSASXLTXXRGRH-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]-2-phenylacetic acid Chemical compound C1=C2C(N=C(N)N)=NC=C(Cl)C2=CC=C1C(=O)NC(C(O)=O)C1=CC=CC=C1 JHSASXLTXXRGRH-UHFFFAOYSA-N 0.000 description 3
- RVVUYQLRIURYNP-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]-3-phenylpropanoic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1C(=O)NC(C(O)=O)CC1=CC=CC=C1 RVVUYQLRIURYNP-UHFFFAOYSA-N 0.000 description 3
- QZWRFXOWKXMZHZ-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]-4-methylpentanoic acid Chemical compound ClC1=CN=C(NC(N)=N)C2=CC(C(=O)NC(CC(C)C)C(O)=O)=CC=C21 QZWRFXOWKXMZHZ-UHFFFAOYSA-N 0.000 description 3
- ISCSYIIAJTXZIG-UHFFFAOYSA-N 2-[benzyl-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]acetic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1=CC=CC=C1 ISCSYIIAJTXZIG-UHFFFAOYSA-N 0.000 description 3
- GRYUAOWKPXQBSM-UHFFFAOYSA-N 2-[benzyl-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]methyl]amino]acetic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1CN(CC(O)=O)CC1=CC=CC=C1 GRYUAOWKPXQBSM-UHFFFAOYSA-N 0.000 description 3
- GEAILAYUCGCNKZ-UHFFFAOYSA-N 2-[cyclopentylmethyl-(1,4-dichloroisoquinolin-7-yl)sulfonylamino]acetic acid Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)N(CC(=O)O)CC1CCCC1 GEAILAYUCGCNKZ-UHFFFAOYSA-N 0.000 description 3
- MBXFJGWNDTUZLK-UHFFFAOYSA-N 2-isoquinolin-1-ylguanidine Chemical class C1=CC=C2C(NC(=N)N)=NC=CC2=C1 MBXFJGWNDTUZLK-UHFFFAOYSA-N 0.000 description 3
- FABBVURNVFOHRS-UHFFFAOYSA-N 3-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]propanoic acid Chemical compound C1=C(S(=O)(=O)NCCC(O)=O)C=C2C(NC(=N)N)=NC=C(Cl)C2=C1 FABBVURNVFOHRS-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 206010016654 Fibrosis Diseases 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102000012479 Serine Proteases Human genes 0.000 description 3
- 108010022999 Serine Proteases Proteins 0.000 description 3
- 206010064390 Tumour invasion Diseases 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 230000010072 bone remodeling Effects 0.000 description 3
- 244000309464 bull Species 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000009400 cancer invasion Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 230000004709 cell invasion Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 3
- XDKDVZIQKXUAJE-CZUORRHYSA-N ethyl (1r,2r)-2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclohexane-1-carboxylate Chemical compound CCOC(=O)[C@@H]1CCCC[C@H]1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 XDKDVZIQKXUAJE-CZUORRHYSA-N 0.000 description 3
- JVAIJMJGLRGSCL-CJNGLKHVSA-N ethyl (1r,2s)-2-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]cyclohexane-1-carboxylate Chemical compound CCOC(=O)[C@@H]1CCCC[C@@H]1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 JVAIJMJGLRGSCL-CJNGLKHVSA-N 0.000 description 3
- XFVQLLHETIXZAJ-UHFFFAOYSA-N ethyl 1-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]cyclopentane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)NC1(C(=O)OCC)CCCC1 XFVQLLHETIXZAJ-UHFFFAOYSA-N 0.000 description 3
- NSWKTIPIBOVPPW-UHFFFAOYSA-N ethyl 1-[(1,4-dichloroisoquinoline-7-carbonyl)amino]cyclopentane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1C(=O)NC1(C(=O)OCC)CCCC1 NSWKTIPIBOVPPW-UHFFFAOYSA-N 0.000 description 3
- FUXWRQFSCSLVFG-UHFFFAOYSA-N ethyl 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-methylamino]cyclopentane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)N(C)C1(C(=O)OCC)CCCC1 FUXWRQFSCSLVFG-UHFFFAOYSA-N 0.000 description 3
- MOLPQBLNDGXPBK-UHFFFAOYSA-N ethyl 1-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]cyclopentane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1C(=O)NC1(C(=O)OCC)CCCC1 MOLPQBLNDGXPBK-UHFFFAOYSA-N 0.000 description 3
- ADFASIQRQWKXSJ-UHFFFAOYSA-N ethyl 1-aminocyclopentane-1-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)C1(N)CCCC1 ADFASIQRQWKXSJ-UHFFFAOYSA-N 0.000 description 3
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 3
- 230000004761 fibrosis Effects 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000007327 hydrogenolysis reaction Methods 0.000 description 3
- 210000002865 immune cell Anatomy 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 230000001394 metastastic effect Effects 0.000 description 3
- 206010061289 metastatic neoplasm Diseases 0.000 description 3
- USKLNUIACYRUJK-SSDOTTSWSA-N methyl (2r)-2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]propanoate Chemical compound ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)N[C@H](C)C(=O)OC)=CC=C21 USKLNUIACYRUJK-SSDOTTSWSA-N 0.000 description 3
- ODXIYADHPLOJIB-UHFFFAOYSA-N methyl 4-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]oxane-4-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)NC1(C(=O)OC)CCOCC1 ODXIYADHPLOJIB-UHFFFAOYSA-N 0.000 description 3
- HGBNBQUWANCOJR-UHFFFAOYSA-N methyl 4-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]oxane-4-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)OC)CCOCC1 HGBNBQUWANCOJR-UHFFFAOYSA-N 0.000 description 3
- AZFBPYNPITWILD-UHFFFAOYSA-N methyl 4-aminooxane-4-carboxylate Chemical compound COC(=O)C1(N)CCOCC1 AZFBPYNPITWILD-UHFFFAOYSA-N 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000016087 ovulation Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 230000021595 spermatogenesis Effects 0.000 description 3
- PRBFGHIWCWVLRQ-PBHICJAKSA-N tert-butyl (1r,2s)-2-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]cyclohexane-1-carboxylate Chemical compound CC(C)(C)OC(=O)[C@@H]1CCCC[C@@H]1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 PRBFGHIWCWVLRQ-PBHICJAKSA-N 0.000 description 3
- GSIFMMNNDXIWMR-PBHICJAKSA-N tert-butyl (1r,2s)-2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclohexane-1-carboxylate Chemical compound CC(C)(C)OC(=O)[C@@H]1CCCC[C@@H]1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 GSIFMMNNDXIWMR-PBHICJAKSA-N 0.000 description 3
- OCDVWGNSUMCOHV-XFULWGLBSA-N tert-butyl (2r)-1-[4-bromo-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylpyrrolidine-2-carboxylate;hydrochloride Chemical compound Cl.CC(C)(C)OC(=O)[C@H]1CCCN1S(=O)(=O)C1=CC=C(C(Br)=CN=C2NC(N)=N)C2=C1 OCDVWGNSUMCOHV-XFULWGLBSA-N 0.000 description 3
- JRTCUNBQTYBCDT-UHFFFAOYSA-N tert-butyl 1-(1,4-dichloroisoquinoline-7-carbonyl)pyrrolidine-2-carboxylate Chemical compound CC(C)(C)OC(=O)C1CCCN1C(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 JRTCUNBQTYBCDT-UHFFFAOYSA-N 0.000 description 3
- OGCHZLXCRHPOMZ-UHFFFAOYSA-N tert-butyl 2-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]benzoate Chemical compound CC(C)(C)OC(=O)C1=CC=CC=C1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 OGCHZLXCRHPOMZ-UHFFFAOYSA-N 0.000 description 3
- LLTUGVPFSXNQMO-UHFFFAOYSA-N tert-butyl 2-[(1,4-dichloroisoquinoline-7-carbonyl)amino]-3-[(2-methylpropan-2-yl)oxy]propanoate Chemical compound ClC1=CN=C(Cl)C2=CC(C(=O)NC(COC(C)(C)C)C(=O)OC(C)(C)C)=CC=C21 LLTUGVPFSXNQMO-UHFFFAOYSA-N 0.000 description 3
- JNDYHOGEYBOCCM-UHFFFAOYSA-N tert-butyl 2-[(1,4-dichloroisoquinoline-7-carbonyl)amino]-3-methylbutanoate Chemical compound ClC1=CN=C(Cl)C2=CC(C(=O)NC(C(C)C)C(=O)OC(C)(C)C)=CC=C21 JNDYHOGEYBOCCM-UHFFFAOYSA-N 0.000 description 3
- ICWWEEXMUFXMQT-UHFFFAOYSA-N tert-butyl 2-[(1,4-dichloroisoquinoline-7-carbonyl)amino]-3-phenylpropanoate Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1C(=O)NC(C(=O)OC(C)(C)C)CC1=CC=CC=C1 ICWWEEXMUFXMQT-UHFFFAOYSA-N 0.000 description 3
- YYKMONSLEMEASL-UHFFFAOYSA-N tert-butyl 2-[(1,4-dichloroisoquinoline-7-carbonyl)amino]-4-methylpentanoate Chemical compound ClC1=CN=C(Cl)C2=CC(C(=O)NC(CC(C)C)C(=O)OC(C)(C)C)=CC=C21 YYKMONSLEMEASL-UHFFFAOYSA-N 0.000 description 3
- FQQGCTUIZNXLND-UHFFFAOYSA-N tert-butyl 2-[(4-methoxyphenyl)methylamino]acetate Chemical compound COC1=CC=C(CNCC(=O)OC(C)(C)C)C=C1 FQQGCTUIZNXLND-UHFFFAOYSA-N 0.000 description 3
- HDXMPGOKFMBDHJ-UHFFFAOYSA-N tert-butyl 2-aminobenzoate Chemical compound CC(C)(C)OC(=O)C1=CC=CC=C1N HDXMPGOKFMBDHJ-UHFFFAOYSA-N 0.000 description 3
- MYBNTSLQHDGJFY-UHFFFAOYSA-N tert-butyl 2-anilinoacetate Chemical compound CC(C)(C)OC(=O)CNC1=CC=CC=C1 MYBNTSLQHDGJFY-UHFFFAOYSA-N 0.000 description 3
- NTTOSTKJCKYXMS-UHFFFAOYSA-N tert-butyl 3-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]benzoate Chemical compound CC(C)(C)OC(=O)C1=CC=CC(NS(=O)(=O)C=2C=C3C(NC(N)=N)=NC=C(Cl)C3=CC=2)=C1 NTTOSTKJCKYXMS-UHFFFAOYSA-N 0.000 description 3
- YGIRNXMYJLWFLH-UHFFFAOYSA-N tert-butyl 3-aminobenzoate Chemical compound CC(C)(C)OC(=O)C1=CC=CC(N)=C1 YGIRNXMYJLWFLH-UHFFFAOYSA-N 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- SJEBRBJOSDSFFJ-GGMFNZDASA-N (1r,2s)-2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclohexane-1-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N[C@H]1CCCC[C@H]1C(O)=O SJEBRBJOSDSFFJ-GGMFNZDASA-N 0.000 description 2
- CLYYEXAIMZOORP-LBPRGKRZSA-N (2R)-2-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]-3,3-dimethylbutanoic acid Chemical compound ClC1=CN=C(Cl)C2=CC(S(=O)(=O)N[C@H](C(C)(C)C)C(O)=O)=CC=C21 CLYYEXAIMZOORP-LBPRGKRZSA-N 0.000 description 2
- YKFJTIJJLBTWKD-GFCCVEGCSA-N (2R)-2-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]-3-methylbutanoic acid Chemical compound ClC1=CN=C(Cl)C2=CC(S(=O)(=O)N[C@H](C(C)C)C(O)=O)=CC=C21 YKFJTIJJLBTWKD-GFCCVEGCSA-N 0.000 description 2
- MPQOREHNRHHMOB-GFCCVEGCSA-N (2r)-1-(1,4-dichloroisoquinolin-7-yl)sulfonylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1CCCN1S(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 MPQOREHNRHHMOB-GFCCVEGCSA-N 0.000 description 2
- HYRNCYNDKFUWJR-UTONKHPSSA-N (2r)-1-[1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylpyrrolidine-2-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=CC2=CC=C1S(=O)(=O)N1CCC[C@@H]1C(O)=O HYRNCYNDKFUWJR-UTONKHPSSA-N 0.000 description 2
- NYKNXEDMEAIPCU-UTONKHPSSA-N (2r)-1-[4-bromo-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylpyrrolidine-2-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Br)C2=CC=C1S(=O)(=O)N1CCC[C@@H]1C(O)=O NYKNXEDMEAIPCU-UTONKHPSSA-N 0.000 description 2
- RRHQRHGBTLXWPQ-CQSZACIVSA-N (2r)-1-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-n-(2-hydroxyethyl)pyrrolidine-2-carboxamide Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N1CCC[C@@H]1C(=O)NCCO RRHQRHGBTLXWPQ-CQSZACIVSA-N 0.000 description 2
- FYIDKYAWXAKKLQ-BTQNPOSSSA-N (2r)-1-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylpiperidine-2-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N1CCCC[C@@H]1C(O)=O FYIDKYAWXAKKLQ-BTQNPOSSSA-N 0.000 description 2
- NMLXXSFWQSUYTC-GFCCVEGCSA-N (2r)-1-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylpyrrolidine-2-carboxamide Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N1CCC[C@@H]1C(N)=O NMLXXSFWQSUYTC-GFCCVEGCSA-N 0.000 description 2
- VVRMPAFFZMVHMH-UTONKHPSSA-N (2r)-1-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylpyrrolidine-2-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N1CCC[C@@H]1C(O)=O VVRMPAFFZMVHMH-UTONKHPSSA-N 0.000 description 2
- BLOOPJZYRFFEJI-SNVBAGLBSA-N (2r)-2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]butanedioic acid Chemical compound C1=C(S(=O)(=O)N[C@H](CC(O)=O)C(O)=O)C=C2C(N=C(N)N)=NC=C(Cl)C2=C1 BLOOPJZYRFFEJI-SNVBAGLBSA-N 0.000 description 2
- AJASBPFHCRVVKL-FYZOBXCZSA-N (2r)-2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]propanoic acid;hydrochloride Chemical compound Cl.ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)N[C@H](C)C(O)=O)=CC=C21 AJASBPFHCRVVKL-FYZOBXCZSA-N 0.000 description 2
- JHSASXLTXXRGRH-OAHLLOKOSA-N (2r)-2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]-2-phenylacetic acid Chemical compound C1([C@H](C(O)=O)NC(=O)C2=CC=C3C(Cl)=CN=C(C3=C2)N=C(N)N)=CC=CC=C1 JHSASXLTXXRGRH-OAHLLOKOSA-N 0.000 description 2
- LGQADKJMGQHVKZ-UHFFFAOYSA-N 1,4-dichloroisoquinoline-7-carboxylic acid Chemical compound ClC1=CN=C(Cl)C2=CC(C(=O)O)=CC=C21 LGQADKJMGQHVKZ-UHFFFAOYSA-N 0.000 description 2
- SLXLIRUDSAJOEX-UHFFFAOYSA-N 1-[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]pyrrolidine-2-carboxylic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1C(=O)N1CCCC1C(O)=O SLXLIRUDSAJOEX-UHFFFAOYSA-N 0.000 description 2
- FYWPVRJASJZPND-UHFFFAOYSA-N 1-[[4-bromo-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[2-(dimethylamino)ethyl]amino]-2-ethylcyclopentane-1-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.CCC1CCCC1(C(O)=O)N(CCN(C)C)S(=O)(=O)C1=CC=C(C(Br)=CN=C2NC(N)=N)C2=C1 FYWPVRJASJZPND-UHFFFAOYSA-N 0.000 description 2
- AFZDACZZKMGLAU-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-(2-hydroxyethyl)amino]-n,n-dimethylcyclopentane-1-carboxamide;hydrochloride Chemical compound Cl.C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)N(CCO)C1(C(=O)N(C)C)CCCC1 AFZDACZZKMGLAU-UHFFFAOYSA-N 0.000 description 2
- AVIKOFVIWUJCJU-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[2-(oxan-2-yloxy)ethyl]amino]-n,n-dimethylcyclopentane-1-carboxamide Chemical compound C1CCCOC1OCCN(S(=O)(=O)C=1C=C2C(NC(N)=N)=NC=C(Cl)C2=CC=1)C1(C(=O)N(C)C)CCCC1 AVIKOFVIWUJCJU-UHFFFAOYSA-N 0.000 description 2
- PBFXRWVLBFCQCW-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-methylamino]cyclopentane-1-carboxylic acid;hydrochloride Chemical compound Cl.C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)N(C)C1(C(O)=O)CCCC1 PBFXRWVLBFCQCW-UHFFFAOYSA-N 0.000 description 2
- IYYRRUPGOBWIJF-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-n-(2-hydroxyethyl)-n-methylcyclopentane-1-carboxamide;hydrochloride Chemical compound Cl.C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)N(CCO)C)CCCC1 IYYRRUPGOBWIJF-UHFFFAOYSA-N 0.000 description 2
- ZWHAXYGLJPNGCY-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-n-(2-methoxyethyl)cyclopentane-1-carboxamide;hydrochloride Chemical compound Cl.C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)NCCOC)CCCC1 ZWHAXYGLJPNGCY-UHFFFAOYSA-N 0.000 description 2
- LDKASNKJBPFBKL-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclobutane-1-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(O)=O)CCC1 LDKASNKJBPFBKL-UHFFFAOYSA-N 0.000 description 2
- SIEBWFXRNISWTR-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclopentane-1-carboxylic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(O)=O)CCCC1 SIEBWFXRNISWTR-UHFFFAOYSA-N 0.000 description 2
- FPRNNZYAUOXVBV-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]cyclopentane-1-carboxylic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1C(=O)NC1(C(O)=O)CCCC1 FPRNNZYAUOXVBV-UHFFFAOYSA-N 0.000 description 2
- VIWYWRSFQRIVPI-UHFFFAOYSA-N 2,4-ditert-butyl-5-nitrophenol Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=C([N+]([O-])=O)C=C1O VIWYWRSFQRIVPI-UHFFFAOYSA-N 0.000 description 2
- YIHCKZKEKWQDFC-UHFFFAOYSA-N 2-(n-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylanilino)acetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2C(N=C(N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)C1=CC=CC=C1 YIHCKZKEKWQDFC-UHFFFAOYSA-N 0.000 description 2
- BTPOPPOVMPRWAI-UHFFFAOYSA-N 2-[(1,4-dichloroisoquinolin-7-yl)sulfonyl-[(2-methoxyphenyl)methyl]amino]acetic acid Chemical compound COC1=CC=CC=C1CN(CC(O)=O)S(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 BTPOPPOVMPRWAI-UHFFFAOYSA-N 0.000 description 2
- JONXVMDKEDXNSM-UHFFFAOYSA-N 2-[(1,4-dichloroisoquinolin-7-yl)sulfonyl-[(2-methylphenyl)methyl]amino]acetic acid Chemical compound CC1=CC=CC=C1CN(CC(O)=O)S(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 JONXVMDKEDXNSM-UHFFFAOYSA-N 0.000 description 2
- NQRHNLPKJODLTJ-UHFFFAOYSA-N 2-[(1,4-dichloroisoquinolin-7-yl)sulfonyl-[(3-methoxyphenyl)methyl]amino]acetic acid Chemical compound COC1=CC=CC(CN(CC(O)=O)S(=O)(=O)C=2C=C3C(Cl)=NC=C(Cl)C3=CC=2)=C1 NQRHNLPKJODLTJ-UHFFFAOYSA-N 0.000 description 2
- ZRGAQZDWAZYHTA-UHFFFAOYSA-N 2-[(1,4-dichloroisoquinolin-7-yl)sulfonyl-[(4-methoxyphenyl)methyl]amino]acetic acid Chemical compound C1=CC(OC)=CC=C1CN(CC(O)=O)S(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 ZRGAQZDWAZYHTA-UHFFFAOYSA-N 0.000 description 2
- XAGKXNQRPYVLNY-UHFFFAOYSA-N 2-[(1,4-dichloroisoquinolin-7-yl)sulfonyl-methylamino]acetic acid Chemical compound ClC1=CN=C(Cl)C2=CC(S(=O)(=O)N(CC(O)=O)C)=CC=C21 XAGKXNQRPYVLNY-UHFFFAOYSA-N 0.000 description 2
- SSBJXDPEIXGMJJ-UHFFFAOYSA-N 2-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]-2-methylpropanamide Chemical compound ClC1=CN=C(Cl)C2=CC(S(=O)(=O)NC(C)(C)C(N)=O)=CC=C21 SSBJXDPEIXGMJJ-UHFFFAOYSA-N 0.000 description 2
- CGVSGFNXYGGAHZ-UHFFFAOYSA-N 2-[(3-chlorophenyl)methyl-(1,4-dichloroisoquinolin-7-yl)sulfonylamino]acetic acid Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)N(CC(=O)O)CC1=CC=CC(Cl)=C1 CGVSGFNXYGGAHZ-UHFFFAOYSA-N 0.000 description 2
- LZYBKPISUPUAAF-SBSPUUFOSA-N 2-[4-chloro-7-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]sulfonylisoquinolin-1-yl]guanidine;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N1CCC[C@@H]1CO LZYBKPISUPUAAF-SBSPUUFOSA-N 0.000 description 2
- OPBOLPCIKIWUGT-UHFFFAOYSA-N 2-[4-chloro-7-[[1-(hydroxymethyl)cyclopentyl]sulfamoyl]isoquinolin-1-yl]guanidine;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(CO)CCCC1 OPBOLPCIKIWUGT-UHFFFAOYSA-N 0.000 description 2
- XPUMANYURZTNDI-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]methyl-methylamino]-2-phenylacetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=C2C(Cl)=CN=C(N=C(N)N)C2=CC=1CN(C)C(C(O)=O)C1=CC=CC=C1 XPUMANYURZTNDI-UHFFFAOYSA-N 0.000 description 2
- GDPRFZQQBIKJDH-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-(cyclohexylmethyl)amino]acetic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1CCCCC1 GDPRFZQQBIKJDH-UHFFFAOYSA-N 0.000 description 2
- YZNIBXPXGCOODS-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-(pyridin-2-ylmethyl)amino]acetic acid Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1=CC=CC=N1 YZNIBXPXGCOODS-UHFFFAOYSA-N 0.000 description 2
- AMGATBXWBRIFHQ-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-(pyridin-2-ylmethyl)amino]acetic acid;dihydrochloride Chemical compound Cl.Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1=CC=CC=N1 AMGATBXWBRIFHQ-UHFFFAOYSA-N 0.000 description 2
- HPXCXDMXXAMAJA-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-(pyridin-3-ylmethyl)amino]acetic acid;dihydrochloride Chemical compound Cl.Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1=CC=CN=C1 HPXCXDMXXAMAJA-UHFFFAOYSA-N 0.000 description 2
- ZTDFFYNFVLEXCF-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-(pyridin-4-ylmethyl)amino]acetic acid;dihydrochloride Chemical compound Cl.Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1=CC=NC=C1 ZTDFFYNFVLEXCF-UHFFFAOYSA-N 0.000 description 2
- VWLQOCGRPVXLHQ-UTONKHPSSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[(1r)-1-phenylethyl]amino]acetic acid;hydrochloride Chemical compound Cl.C1([C@H](N(CC(O)=O)S(=O)(=O)C=2C=C3C(NC(N)=N)=NC=C(Cl)C3=CC=2)C)=CC=CC=C1 VWLQOCGRPVXLHQ-UTONKHPSSA-N 0.000 description 2
- VWLQOCGRPVXLHQ-YDALLXLXSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[(1s)-1-phenylethyl]amino]acetic acid;hydrochloride Chemical compound Cl.C1([C@@H](N(CC(O)=O)S(=O)(=O)C=2C=C3C(NC(N)=N)=NC=C(Cl)C3=CC=2)C)=CC=CC=C1 VWLQOCGRPVXLHQ-YDALLXLXSA-N 0.000 description 2
- JXFSTYPSWCYYEO-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[(2-methoxyphenyl)methyl]amino]acetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=CC=CC=C1CN(CC(O)=O)S(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 JXFSTYPSWCYYEO-UHFFFAOYSA-N 0.000 description 2
- MFLWOIMFSLYVTE-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[(2-methylphenyl)methyl]amino]acetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=CC=CC=C1CN(CC(O)=O)S(=O)(=O)C1=CC=C(C(Cl)=CN=C2N=C(N)N)C2=C1 MFLWOIMFSLYVTE-UHFFFAOYSA-N 0.000 description 2
- JYLJFWCPRHSAFV-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[(3-chlorophenyl)methyl]amino]acetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2C(N=C(N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1=CC=CC(Cl)=C1 JYLJFWCPRHSAFV-UHFFFAOYSA-N 0.000 description 2
- YSILPIWCDPHDRP-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-methylamino]acetic acid Chemical compound ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)N(CC(O)=O)C)=CC=C21 YSILPIWCDPHDRP-UHFFFAOYSA-N 0.000 description 2
- IVWAPNVGSPSJEA-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-methylamino]acetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)N(CC(O)=O)C)=CC=C21 IVWAPNVGSPSJEA-UHFFFAOYSA-N 0.000 description 2
- BOXJDXJDFRZOOE-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-2-methylpropanamide;hydrochloride Chemical compound Cl.ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)NC(C)(C)C(N)=O)=CC=C21 BOXJDXJDFRZOOE-UHFFFAOYSA-N 0.000 description 2
- KZPZBUWGZWWKRZ-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]-2-cyclopentylacetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2C(N=C(N)N)=NC=C(Cl)C2=CC=C1C(=O)NC(C(O)=O)C1CCCC1 KZPZBUWGZWWKRZ-UHFFFAOYSA-N 0.000 description 2
- HHJBMGZABPQWSO-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]-3-hydroxypropanoic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C(=O)NC(CO)C(O)=O)C=C2C(N=C(N)N)=NC=C(Cl)C2=C1 HHJBMGZABPQWSO-UHFFFAOYSA-N 0.000 description 2
- DFHXYACJRDMJNE-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]-3-methylbutanoic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.ClC1=CN=C(NC(N)=N)C2=CC(C(=O)NC(C(C)C)C(O)=O)=CC=C21 DFHXYACJRDMJNE-UHFFFAOYSA-N 0.000 description 2
- APWMDKWPHBPGRI-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]-3-phenylpropanoic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1C(=O)NC(C(O)=O)CC1=CC=CC=C1 APWMDKWPHBPGRI-UHFFFAOYSA-N 0.000 description 2
- AZJSTAJPTHFANN-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]-4-methylpentanoic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.ClC1=CN=C(NC(N)=N)C2=CC(C(=O)NC(CC(C)C)C(O)=O)=CC=C21 AZJSTAJPTHFANN-UHFFFAOYSA-N 0.000 description 2
- BKFJIRZEVMYGIC-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]acetic acid Chemical compound C1=C(C(=O)NCC(O)=O)C=C2C(NC(=N)N)=NC=C(Cl)C2=C1 BKFJIRZEVMYGIC-UHFFFAOYSA-N 0.000 description 2
- AWTGDYUUCNUVPX-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]acetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C(=O)NCC(O)=O)C=C2C(N=C(N)N)=NC=C(Cl)C2=C1 AWTGDYUUCNUVPX-UHFFFAOYSA-N 0.000 description 2
- MNFCGXPRYMJSQU-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]butanedioic acid Chemical compound C1=C(C(=O)NC(CC(O)=O)C(O)=O)C=C2C(NC(=N)N)=NC=C(Cl)C2=C1 MNFCGXPRYMJSQU-UHFFFAOYSA-N 0.000 description 2
- QEINCTOKPHAHRH-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]butanedioic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C(=O)NC(CC(O)=O)C(O)=O)C=C2C(NC(=N)N)=NC=C(Cl)C2=C1 QEINCTOKPHAHRH-UHFFFAOYSA-N 0.000 description 2
- JFZBBUPMJXURCH-UHFFFAOYSA-N 2-[benzyl-(1,4-dichloroisoquinolin-7-yl)sulfonylamino]acetic acid Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)N(CC(=O)O)CC1=CC=CC=C1 JFZBBUPMJXURCH-UHFFFAOYSA-N 0.000 description 2
- HKKWVXONIITRLP-UHFFFAOYSA-N 2-[benzyl-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]acetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2C(N=C(N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1=CC=CC=C1 HKKWVXONIITRLP-UHFFFAOYSA-N 0.000 description 2
- HZQVDAUIBDEMQZ-UHFFFAOYSA-N 2-[benzyl-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]methyl]amino]acetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.C1=C2C(N=C(N)N)=NC=C(Cl)C2=CC=C1CN(CC(O)=O)CC1=CC=CC=C1 HZQVDAUIBDEMQZ-UHFFFAOYSA-N 0.000 description 2
- BIOUKLXWWSNAJT-UHFFFAOYSA-N 2-[carboxymethyl-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]acetic acid;hydrochloride Chemical compound Cl.C1=C(S(=O)(=O)N(CC(O)=O)CC(O)=O)C=C2C(NC(=N)N)=NC=C(Cl)C2=C1 BIOUKLXWWSNAJT-UHFFFAOYSA-N 0.000 description 2
- GOHSKRBVVFCLDO-UHFFFAOYSA-N 2-bromo-2-chloro-2-fluoroacetic acid Chemical compound OC(=O)C(F)(Cl)Br GOHSKRBVVFCLDO-UHFFFAOYSA-N 0.000 description 2
- HYRUDSODWCYZBP-UHFFFAOYSA-N 3-(4-bromophenyl)prop-2-enoyl azide Chemical compound BrC1=CC=C(C=CC(=O)N=[N+]=[N-])C=C1 HYRUDSODWCYZBP-UHFFFAOYSA-N 0.000 description 2
- YLABICHHIYWLQM-UHFFFAOYSA-N 3-(4-bromophenyl)prop-2-enoyl chloride Chemical compound ClC(=O)C=CC1=CC=C(Br)C=C1 YLABICHHIYWLQM-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- MCWFZUYARBFPMQ-UHFFFAOYSA-N 4-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]oxane-4-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(O)=O)CCOCC1 MCWFZUYARBFPMQ-UHFFFAOYSA-N 0.000 description 2
- BKJUCAQGGKWKRQ-UHFFFAOYSA-N 4-chloro-1-oxo-2h-isoquinoline-7-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=C2C(Cl)=CNC(=O)C2=C1 BKJUCAQGGKWKRQ-UHFFFAOYSA-N 0.000 description 2
- MVWIXKFNHOXLBU-UHFFFAOYSA-N 4-chloro-2h-isoquinolin-1-one Chemical compound C1=CC=C2C(Cl)=CNC(=O)C2=C1 MVWIXKFNHOXLBU-UHFFFAOYSA-N 0.000 description 2
- CRMZCAZKRFJYRV-UHFFFAOYSA-N 5-(4-amino-1,3-dimethyl-2,6-dioxopyrimidin-5-yl)-6-(5-chlorothiophen-2-yl)-1,3-dimethyl-7h-pyrrolo[2,3-d]pyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)N(C)C(N)=C1C1=C(C=2SC(Cl)=CC=2)NC2=C1C(=O)N(C)C(=O)N2C CRMZCAZKRFJYRV-UHFFFAOYSA-N 0.000 description 2
- YRWRDWYNNLDIAJ-UHFFFAOYSA-N 7-bromo-4-chloro-2h-isoquinolin-1-one Chemical compound BrC1=CC=C2C(Cl)=CNC(=O)C2=C1 YRWRDWYNNLDIAJ-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- UERLULLEBSMPOQ-JOCQHMNTSA-N C1C[C@@H](C(=O)OC(C)(C)C)CC[C@@H]1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 Chemical compound C1C[C@@H](C(=O)OC(C)(C)C)CC[C@@H]1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 UERLULLEBSMPOQ-JOCQHMNTSA-N 0.000 description 2
- DQYOKLRDMJNFMK-HAQNSBGRSA-N C1C[C@@H](C(=O)OCC)CC[C@@H]1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 Chemical compound C1C[C@@H](C(=O)OCC)CC[C@@H]1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 DQYOKLRDMJNFMK-HAQNSBGRSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 2
- NZNMSOFKMUBTKW-UHFFFAOYSA-N Cyclohexanecarboxylic acid Natural products OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PPXYIKWUERSBMJ-UHFFFAOYSA-N FC(C(=O)O)(F)F.ClC1=CN=C(C2=CC(=CC=C12)C(=O)NC(C1=CC=CC=C1)C(=O)O)NC(=N)N Chemical compound FC(C(=O)O)(F)F.ClC1=CN=C(C2=CC(=CC=C12)C(=O)NC(C1=CC=CC=C1)C(=O)O)NC(=N)N PPXYIKWUERSBMJ-UHFFFAOYSA-N 0.000 description 2
- PPXYIKWUERSBMJ-XFULWGLBSA-N FC(C(=O)O)(F)F.ClC1=CN=C(C2=CC(=CC=C12)C(=O)N[C@H](C1=CC=CC=C1)C(=O)O)NC(=N)N Chemical compound FC(C(=O)O)(F)F.ClC1=CN=C(C2=CC(=CC=C12)C(=O)N[C@H](C1=CC=CC=C1)C(=O)O)NC(=N)N PPXYIKWUERSBMJ-XFULWGLBSA-N 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 2
- 206010029113 Neovascularisation Diseases 0.000 description 2
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 2
- 229910019213 POCl3 Inorganic materials 0.000 description 2
- 102000013566 Plasminogen Human genes 0.000 description 2
- 108010051456 Plasminogen Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229910006024 SO2Cl2 Inorganic materials 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
- NYIQMVLYUBBRPN-SECBINFHSA-N [(2r)-1-(1,4-dichloroisoquinolin-7-yl)sulfonylpyrrolidin-2-yl]methanol Chemical compound OC[C@H]1CCCN1S(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 NYIQMVLYUBBRPN-SECBINFHSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 description 2
- ISQVBYGGNVVVHB-UHFFFAOYSA-N cyclopentylmethanol Chemical compound OCC1CCCC1 ISQVBYGGNVVVHB-UHFFFAOYSA-N 0.000 description 2
- ZNKNSUYQWBHTFD-MRXNPFEDSA-N ditert-butyl (2r)-2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]butanedioate Chemical compound ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)N[C@H](CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C)=CC=C21 ZNKNSUYQWBHTFD-MRXNPFEDSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000010931 ester hydrolysis Methods 0.000 description 2
- OKKPNBJEAZBKDF-UHFFFAOYSA-N ethyl 1,4-dichloroisoquinoline-7-carboxylate Chemical compound ClC1=CN=C(Cl)C2=CC(C(=O)OCC)=CC=C21 OKKPNBJEAZBKDF-UHFFFAOYSA-N 0.000 description 2
- GSFIBGRNPWNGME-UHFFFAOYSA-N ethyl 1-[(1,4-dichloroisoquinolin-7-yl)sulfonyl-[2-(dimethylamino)ethyl]amino]cyclopentane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)N(CCN(C)C)C1(C(=O)OCC)CCCC1 GSFIBGRNPWNGME-UHFFFAOYSA-N 0.000 description 2
- QXYFTOZQCJKISW-UHFFFAOYSA-N ethyl 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[2-(dimethylamino)ethyl]amino]cyclopentane-1-carboxylate;dihydrochloride Chemical compound Cl.Cl.C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)N(CCN(C)C)C1(C(=O)OCC)CCCC1 QXYFTOZQCJKISW-UHFFFAOYSA-N 0.000 description 2
- KEPSIMOVRWXUOT-UHFFFAOYSA-N ethyl 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[2-(oxan-2-yloxy)ethyl]amino]cyclopentane-1-carboxylate Chemical compound C1CCCOC1OCCN(S(=O)(=O)C=1C=C2C(NC(N)=N)=NC=C(Cl)C2=CC=1)C1(C(=O)OCC)CCCC1 KEPSIMOVRWXUOT-UHFFFAOYSA-N 0.000 description 2
- QWYQMCPQTSVEAQ-UHFFFAOYSA-N ethyl 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]amino]cyclopentane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)N(CC(=O)OC(C)(C)C)C1(C(=O)OCC)CCCC1 QWYQMCPQTSVEAQ-UHFFFAOYSA-N 0.000 description 2
- UDEIQVPDPNKDCJ-UHFFFAOYSA-N ethyl 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclobutane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)OCC)CCC1 UDEIQVPDPNKDCJ-UHFFFAOYSA-N 0.000 description 2
- ZLWOYEWRYSUZPY-UHFFFAOYSA-N ethyl 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclopentane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)OCC)CCCC1 ZLWOYEWRYSUZPY-UHFFFAOYSA-N 0.000 description 2
- YGAYWFFKRVMVBL-UHFFFAOYSA-N ethyl 1-aminocyclobutane-1-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)C1(N)CCC1 YGAYWFFKRVMVBL-UHFFFAOYSA-N 0.000 description 2
- NLLGKNYQDQBMFW-UHFFFAOYSA-N ethyl 1-aminocyclopentane-1-carboxylate Chemical compound CCOC(=O)C1(N)CCCC1 NLLGKNYQDQBMFW-UHFFFAOYSA-N 0.000 description 2
- KZEMDYLFNDBMTG-UHFFFAOYSA-N ethyl 3-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-2,2-dimethylpropanoate;hydrochloride Chemical compound Cl.ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)NCC(C)(C)C(=O)OCC)=CC=C21 KZEMDYLFNDBMTG-UHFFFAOYSA-N 0.000 description 2
- WASRJUXSLHUONH-UHFFFAOYSA-N ethyl 4-aminocyclohexane-1-carboxylate Chemical compound CCOC(=O)C1CCC(N)CC1 WASRJUXSLHUONH-UHFFFAOYSA-N 0.000 description 2
- QAKKFOLTBGZECT-UHFFFAOYSA-N ethyl 4-chloro-1-oxo-2h-isoquinoline-7-carboxylate Chemical compound ClC1=CNC(=O)C2=CC(C(=O)OCC)=CC=C21 QAKKFOLTBGZECT-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 230000003480 fibrinolytic effect Effects 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- BJUJDDATZZBTGL-SSDOTTSWSA-N methyl (2r)-2-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]propanoate Chemical compound ClC1=CN=C(Cl)C2=CC(S(=O)(=O)N[C@H](C)C(=O)OC)=CC=C21 BJUJDDATZZBTGL-SSDOTTSWSA-N 0.000 description 2
- JTUMJKKWQZYPPL-UHFFFAOYSA-N methyl 1-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]cyclohexane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)NC1(C(=O)OC)CCCCC1 JTUMJKKWQZYPPL-UHFFFAOYSA-N 0.000 description 2
- WMTHWSWQCXSBOV-UHFFFAOYSA-N methyl 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]methylamino]cyclopentane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1CNC1(C(=O)OC)CCCC1 WMTHWSWQCXSBOV-UHFFFAOYSA-N 0.000 description 2
- MDQKGIOLJDBGLT-UHFFFAOYSA-N methyl 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclohexane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)OC)CCCCC1 MDQKGIOLJDBGLT-UHFFFAOYSA-N 0.000 description 2
- JHXBMPDRUXACBV-UHFFFAOYSA-N methyl 3-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]-4-methoxybenzoate Chemical compound COC(=O)C1=CC=C(OC)C(NS(=O)(=O)C=2C=C3C(Cl)=NC=C(Cl)C3=CC=2)=C1 JHXBMPDRUXACBV-UHFFFAOYSA-N 0.000 description 2
- PHCLQRSGYBYJAJ-UHFFFAOYSA-N methyl 3-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-4-methoxybenzoate Chemical compound COC(=O)C1=CC=C(OC)C(NS(=O)(=O)C=2C=C3C(NC(N)=N)=NC=C(Cl)C3=CC=2)=C1 PHCLQRSGYBYJAJ-UHFFFAOYSA-N 0.000 description 2
- MMQNBCUIOPBHRQ-UHFFFAOYSA-N methyl 4-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-1-methylpiperidine-4-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)OC)CCN(C)CC1 MMQNBCUIOPBHRQ-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 2
- 150000002825 nitriles Chemical group 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 230000006340 racemization Effects 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- TZHVYFBSLOMRCU-YFKPBYRVSA-N tert-butyl (2s)-2-aminopropanoate Chemical compound C[C@H](N)C(=O)OC(C)(C)C TZHVYFBSLOMRCU-YFKPBYRVSA-N 0.000 description 2
- UURAHTSUPDIUNL-UHFFFAOYSA-N tert-butyl 2-(benzylamino)acetate Chemical compound CC(C)(C)OC(=O)CNCC1=CC=CC=C1 UURAHTSUPDIUNL-UHFFFAOYSA-N 0.000 description 2
- KUYMVWXKHQSIAS-UHFFFAOYSA-N tert-butyl 2-chloroacetate Chemical compound CC(C)(C)OC(=O)CCl KUYMVWXKHQSIAS-UHFFFAOYSA-N 0.000 description 2
- DRGCBGCMYGTVIB-UHFFFAOYSA-N tert-butyl 2-nitrobenzoate Chemical compound CC(C)(C)OC(=O)C1=CC=CC=C1[N+]([O-])=O DRGCBGCMYGTVIB-UHFFFAOYSA-N 0.000 description 2
- XOBTVGBENYKVOJ-UHFFFAOYSA-N tert-butyl 3-[(1,4-dichloroisoquinoline-7-carbonyl)amino]propanoate Chemical compound ClC1=CN=C(Cl)C2=CC(C(=O)NCCC(=O)OC(C)(C)C)=CC=C21 XOBTVGBENYKVOJ-UHFFFAOYSA-N 0.000 description 2
- ZJXHVYSDMUKUCA-UHFFFAOYSA-N tert-butyl 3-aminopropanoate Chemical compound CC(C)(C)OC(=O)CCN ZJXHVYSDMUKUCA-UHFFFAOYSA-N 0.000 description 2
- SFFFYEGVQDWTNQ-UHFFFAOYSA-N tert-butyl 3-nitrobenzoate Chemical compound CC(C)(C)OC(=O)C1=CC=CC([N+]([O-])=O)=C1 SFFFYEGVQDWTNQ-UHFFFAOYSA-N 0.000 description 2
- XDTZRQLZSNTGSM-UHFFFAOYSA-N tert-butyl 4-aminocyclohexane-1-carboxylate Chemical compound CC(C)(C)OC(=O)C1CCC(N)CC1 XDTZRQLZSNTGSM-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 150000003585 thioureas Chemical class 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- MYVWJCDGRUONGO-UHFFFAOYSA-N (1-aminocyclopentyl)-(4-methylpiperazin-1-yl)methanone;dihydrochloride Chemical compound Cl.Cl.C1CN(C)CCN1C(=O)C1(N)CCCC1 MYVWJCDGRUONGO-UHFFFAOYSA-N 0.000 description 1
- RQEUFEKYXDPUSK-SSDOTTSWSA-N (1R)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-SSDOTTSWSA-N 0.000 description 1
- RQEUFEKYXDPUSK-ZETCQYMHSA-N (1S)-1-phenylethanamine Chemical compound C[C@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-ZETCQYMHSA-N 0.000 description 1
- PXJACNDVRNAFHD-UHFFFAOYSA-N (2-methoxyphenyl)methanamine Chemical compound COC1=CC=CC=C1CN PXJACNDVRNAFHD-UHFFFAOYSA-N 0.000 description 1
- CJAAPVQEZPAQNI-UHFFFAOYSA-N (2-methylphenyl)methanamine Chemical compound CC1=CC=CC=C1CN CJAAPVQEZPAQNI-UHFFFAOYSA-N 0.000 description 1
- CHXLQXMSRZELLF-MRXNPFEDSA-N (2r)-1-[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-n-[2-(dimethylamino)ethyl]pyrrolidine-2-carboxamide Chemical compound CN(C)CCNC(=O)[C@H]1CCCN1S(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 CHXLQXMSRZELLF-MRXNPFEDSA-N 0.000 description 1
- PYAPIUGPYJOQFC-YDALLXLXSA-N (2r)-2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-3,3-dimethylbutanoic acid;hydrochloride Chemical compound Cl.ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)N[C@H](C(C)(C)C)C(O)=O)=CC=C21 PYAPIUGPYJOQFC-YDALLXLXSA-N 0.000 description 1
- QDDOVGGTVYFMDE-UTONKHPSSA-N (2r)-2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-3-methylbutanoic acid;hydrochloride Chemical compound Cl.ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)N[C@H](C(C)C)C(O)=O)=CC=C21 QDDOVGGTVYFMDE-UTONKHPSSA-N 0.000 description 1
- VTNQDOOHJOBQKC-HNCPQSOCSA-N (2r)-2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]butanedioic acid;hydrochloride Chemical compound Cl.C1=C(S(=O)(=O)N[C@H](CC(O)=O)C(O)=O)C=C2C(NC(=N)N)=NC=C(Cl)C2=C1 VTNQDOOHJOBQKC-HNCPQSOCSA-N 0.000 description 1
- NPDBDJFLKKQMCM-BYPYZUCNSA-N (2r)-2-azaniumyl-3,3-dimethylbutanoate Chemical compound CC(C)(C)[C@@H]([NH3+])C([O-])=O NPDBDJFLKKQMCM-BYPYZUCNSA-N 0.000 description 1
- MPQOREHNRHHMOB-LBPRGKRZSA-N (2s)-1-(1,4-dichloroisoquinolin-7-yl)sulfonylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1S(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 MPQOREHNRHHMOB-LBPRGKRZSA-N 0.000 description 1
- RLIHXKPTGKETCC-QMMMGPOBSA-N (2s)-2-(benzylazaniumyl)propanoate Chemical compound OC(=O)[C@H](C)NCC1=CC=CC=C1 RLIHXKPTGKETCC-QMMMGPOBSA-N 0.000 description 1
- DWHMPBALQYTJFJ-DKWTVANSSA-N (2s)-2-aminobutanedioic acid;hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CC(O)=O DWHMPBALQYTJFJ-DKWTVANSSA-N 0.000 description 1
- GRRIMVWABNHKBX-UHFFFAOYSA-N (3-methoxyphenyl)methanamine Chemical compound COC1=CC=CC(CN)=C1 GRRIMVWABNHKBX-UHFFFAOYSA-N 0.000 description 1
- SWXXKWPYNMZFTE-UHFFFAOYSA-N (c-ethylsulfanylcarbonimidoyl)azanium;bromide Chemical compound Br.CCSC(N)=N SWXXKWPYNMZFTE-UHFFFAOYSA-N 0.000 description 1
- CPDDDTNAMBSPRN-ZZXKWVIFSA-N (e)-3-(4-bromophenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=C(Br)C=C1 CPDDDTNAMBSPRN-ZZXKWVIFSA-N 0.000 description 1
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- ZKOCWDCPANZRPS-UHFFFAOYSA-N 1,4,7-trichloroisoquinoline Chemical compound ClC1=CN=C(Cl)C2=CC(Cl)=CC=C21 ZKOCWDCPANZRPS-UHFFFAOYSA-N 0.000 description 1
- IDPURXSQCKYKIJ-UHFFFAOYSA-N 1-(4-methoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 1
- BXCBUWKTXLWPSB-UHFFFAOYSA-N 1-(chloromethyl)-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1CCl BXCBUWKTXLWPSB-UHFFFAOYSA-N 0.000 description 1
- FVTVMQPGKVHSEY-UHFFFAOYSA-N 1-AMINOCYCLOBUTANE CARBOXYLIC ACID Chemical compound OC(=O)C1(N)CCC1 FVTVMQPGKVHSEY-UHFFFAOYSA-N 0.000 description 1
- BHJHBXRXPODWGU-UHFFFAOYSA-N 1-[3-(1-aminoisoquinolin-6-yl)-1-oxo-1-piperidin-1-ylpropan-2-yl]-3-[(2,2,5,7,8-pentamethyl-3,4-dihydrochromen-6-yl)sulfonylamino]urea Chemical compound CC=1C=2CCC(C)(C)OC=2C(C)=C(C)C=1S(=O)(=O)NNC(=O)NC(CC=1C=C2C=CN=C(N)C2=CC=1)C(=O)N1CCCCC1 BHJHBXRXPODWGU-UHFFFAOYSA-N 0.000 description 1
- CIBSVTIGWIBIPC-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]methylamino]cyclopentane-1-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1CNC1(C(O)=O)CCCC1 CIBSVTIGWIBIPC-UHFFFAOYSA-N 0.000 description 1
- PZIPABXTGFUIRH-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-[2-(dimethylamino)ethyl]amino]-n-(2-hydroxyethyl)-n-methylcyclopentane-1-carboxamide;dihydrochloride Chemical compound Cl.Cl.C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)N(CCN(C)C)C1(C(=O)N(C)CCO)CCCC1 PZIPABXTGFUIRH-UHFFFAOYSA-N 0.000 description 1
- LDQBNBQEPZPATR-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-n-[2-(dimethylamino)ethyl]cyclopentane-1-carboxamide Chemical compound C=1C=C2C(Cl)=CN=C(N=C(N)N)C2=CC=1S(=O)(=O)NC1(C(=O)NCCN(C)C)CCCC1 LDQBNBQEPZPATR-UHFFFAOYSA-N 0.000 description 1
- TWVUMWXBQZRDNJ-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-n-methyl-n-[2-(methylamino)ethyl]cyclopentane-1-carboxamide;hydrochloride Chemical compound Cl.C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)N(C)CCNC)CCCC1 TWVUMWXBQZRDNJ-UHFFFAOYSA-N 0.000 description 1
- FXIJMQHQADSODA-UHFFFAOYSA-N 1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclohexane-1-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(O)=O)CCCCC1 FXIJMQHQADSODA-UHFFFAOYSA-N 0.000 description 1
- NILQLFBWTXNUOE-UHFFFAOYSA-N 1-aminocyclopentanecarboxylic acid Chemical compound OC(=O)C1(N)CCCC1 NILQLFBWTXNUOE-UHFFFAOYSA-N 0.000 description 1
- JZWDLUGQTRKBNA-UHFFFAOYSA-N 1-benzothiophene-2-carboximidamide Chemical class C1=CC=C2SC(C(=N)N)=CC2=C1 JZWDLUGQTRKBNA-UHFFFAOYSA-N 0.000 description 1
- DDGRAFHHXYIQQR-UHFFFAOYSA-N 1-chloro-3-(chloromethyl)benzene Chemical compound ClCC1=CC=CC(Cl)=C1 DDGRAFHHXYIQQR-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- JPMRGPPMXHGKRO-UHFFFAOYSA-N 2-(chloromethyl)pyridine hydrochloride Chemical compound Cl.ClCC1=CC=CC=N1 JPMRGPPMXHGKRO-UHFFFAOYSA-N 0.000 description 1
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 1
- XDDXQEWQVDNIND-UHFFFAOYSA-N 2-[(1,4-dichloroisoquinolin-7-yl)methyl-methylamino]-2-phenylacetic acid Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1CN(C)C(C(O)=O)C1=CC=CC=C1 XDDXQEWQVDNIND-UHFFFAOYSA-N 0.000 description 1
- UGUXSVYJXMQGLC-UHFFFAOYSA-N 2-[4-chloro-7-[[1-(4-methylpiperazine-1-carbonyl)cyclopentyl]sulfamoyl]isoquinolin-1-yl]guanidine;dihydrochloride Chemical compound Cl.Cl.C1CN(C)CCN1C(=O)C1(NS(=O)(=O)C=2C=C3C(NC(N)=N)=NC=C(Cl)C3=CC=2)CCCC1 UGUXSVYJXMQGLC-UHFFFAOYSA-N 0.000 description 1
- TWTODTWQWNOGTP-UHFFFAOYSA-N 2-[4-chloro-7-[[1-(morpholine-4-carbonyl)cyclopentyl]sulfamoyl]isoquinolin-1-yl]guanidine;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1(C(=O)N2CCOCC2)CCCC1 TWTODTWQWNOGTP-UHFFFAOYSA-N 0.000 description 1
- BLGALJLRMMYDNI-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonyl-(cyclopentylmethyl)amino]acetic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N(CC(O)=O)CC1CCCC1 BLGALJLRMMYDNI-UHFFFAOYSA-N 0.000 description 1
- IUBFETAFRGVODB-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-2-methylpropanoic acid;hydrochloride Chemical compound Cl.ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)NC(C)(C)C(O)=O)=CC=C21 IUBFETAFRGVODB-UHFFFAOYSA-N 0.000 description 1
- MCOBQEUHHKLLMS-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]acetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(S(=O)(=O)NCC(O)=O)C=C2C(N=C(N)N)=NC=C(Cl)C2=C1 MCOBQEUHHKLLMS-UHFFFAOYSA-N 0.000 description 1
- SRDUSZRNFSZLPK-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]benzoic acid Chemical compound C1=C2C(N=C(N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1=CC=CC=C1C(O)=O SRDUSZRNFSZLPK-UHFFFAOYSA-N 0.000 description 1
- DWNTUNKHCYBTHJ-UHFFFAOYSA-N 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]benzoic acid;hydrochloride Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1=CC=CC=C1C(O)=O DWNTUNKHCYBTHJ-UHFFFAOYSA-N 0.000 description 1
- RNMYIBXSRMOSAB-UHFFFAOYSA-N 2-[benzyl-(1,4-dichloroisoquinoline-7-carbonyl)amino]acetic acid Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1C(=O)N(CC(=O)O)CC1=CC=CC=C1 RNMYIBXSRMOSAB-UHFFFAOYSA-N 0.000 description 1
- PVSMGMIQTFYTLG-UHFFFAOYSA-N 2-[benzyl-[(1,4-dichloroisoquinolin-7-yl)methyl]amino]acetic acid Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1CN(CC(=O)O)CC1=CC=CC=C1 PVSMGMIQTFYTLG-UHFFFAOYSA-N 0.000 description 1
- RZHLHZRAKGZWTD-UHFFFAOYSA-N 2-[benzyl-[4-chloro-1-(diaminomethylideneamino)isoquinoline-7-carbonyl]amino]acetic acid Chemical compound C1=C2C(N=C(N)N)=NC=C(Cl)C2=CC=C1C(=O)N(CC(O)=O)CC1=CC=CC=C1 RZHLHZRAKGZWTD-UHFFFAOYSA-N 0.000 description 1
- ZIOBGZDFMKCKGZ-UHFFFAOYSA-N 2-amino-2-methylpropanamide Chemical compound CC(C)(N)C(N)=O ZIOBGZDFMKCKGZ-UHFFFAOYSA-N 0.000 description 1
- YSWCBAKPAOEYGF-UHFFFAOYSA-N 2-aminoacetic acid;2,2,2-trifluoroacetic acid Chemical compound NCC(O)=O.OC(=O)C(F)(F)F YSWCBAKPAOEYGF-UHFFFAOYSA-N 0.000 description 1
- WQMAANNAZKNUDL-UHFFFAOYSA-N 2-dimethylaminoethyl chloride Chemical compound CN(C)CCCl WQMAANNAZKNUDL-UHFFFAOYSA-N 0.000 description 1
- ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 1
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- QRJZGVVKGFIGLI-UHFFFAOYSA-N 2-phenylguanidine Chemical class NC(=N)NC1=CC=CC=C1 QRJZGVVKGFIGLI-UHFFFAOYSA-N 0.000 description 1
- SDXAWLJRERMRKF-UHFFFAOYSA-N 3,5-dimethyl-1h-pyrazole Chemical class CC=1C=C(C)NN=1 SDXAWLJRERMRKF-UHFFFAOYSA-N 0.000 description 1
- UZGLOGCJCWBBIV-UHFFFAOYSA-N 3-(chloromethyl)pyridin-1-ium;chloride Chemical compound Cl.ClCC1=CC=CN=C1 UZGLOGCJCWBBIV-UHFFFAOYSA-N 0.000 description 1
- UOHBWYOFMZZGFD-UHFFFAOYSA-N 3-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-2,2-dimethylpropanoic acid;hydrochloride Chemical compound Cl.ClC1=CN=C(NC(N)=N)C2=CC(S(=O)(=O)NCC(C)(C)C(O)=O)=CC=C21 UOHBWYOFMZZGFD-UHFFFAOYSA-N 0.000 description 1
- RDKCZWQZPLEOOK-UHFFFAOYSA-N 3-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2N=C(N)N)C2=C1 RDKCZWQZPLEOOK-UHFFFAOYSA-N 0.000 description 1
- CQXWCXFZBGJXOD-UHFFFAOYSA-N 3-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-4-methoxybenzoic acid;hydrochloride Chemical compound Cl.COC1=CC=C(C(O)=O)C=C1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 CQXWCXFZBGJXOD-UHFFFAOYSA-N 0.000 description 1
- OGVTZTLGWGTMLF-UHFFFAOYSA-N 3-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]benzoic acid Chemical compound C1=C2C(N=C(N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1=CC=CC(C(O)=O)=C1 OGVTZTLGWGTMLF-UHFFFAOYSA-N 0.000 description 1
- GKMIPQRXZFAJAA-UHFFFAOYSA-N 3-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]benzoic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2C(N=C(N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)NC1=CC=CC(C(O)=O)=C1 GKMIPQRXZFAJAA-UHFFFAOYSA-N 0.000 description 1
- IIJSNBWEYVORPD-UHFFFAOYSA-N 3-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]propanoic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(S(=O)(=O)NCCC(O)=O)C=C2C(N=C(N)N)=NC=C(Cl)C2=C1 IIJSNBWEYVORPD-UHFFFAOYSA-N 0.000 description 1
- AFPHTEQTJZKQAQ-UHFFFAOYSA-N 3-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1 AFPHTEQTJZKQAQ-UHFFFAOYSA-N 0.000 description 1
- ZDHKVKPZQKYREU-UHFFFAOYSA-N 4-(chloromethyl)pyridine;hydron;chloride Chemical compound Cl.ClCC1=CC=NC=C1 ZDHKVKPZQKYREU-UHFFFAOYSA-N 0.000 description 1
- YFQCWRFRSGFFTC-UHFFFAOYSA-N 4-(dichloromethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C(Cl)Cl)N=C1C1=CC=CC=C1 YFQCWRFRSGFFTC-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 description 1
- MNVXOHFGWKIQNL-UHFFFAOYSA-N 4-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-1-methylpiperidine-4-carboxylic acid;hydrochloride Chemical compound Cl.C1CN(C)CCC1(C(O)=O)NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 MNVXOHFGWKIQNL-UHFFFAOYSA-N 0.000 description 1
- DPDPQQHHTHKSRN-UHFFFAOYSA-N 4-aminooxane-4-carboxylic acid Chemical compound OC(=O)C1(N)CCOCC1 DPDPQQHHTHKSRN-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- DSOKREQUHLPVFR-UHFFFAOYSA-N 7-bromo-2h-isoquinolin-1-one Chemical compound C1=CNC(=O)C2=CC(Br)=CC=C21 DSOKREQUHLPVFR-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- QMYNQWVHQFVSKA-MGCOHNPYSA-N C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N[C@H]1CC[C@H](C(O)=O)CC1 Chemical compound C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N[C@H]1CC[C@H](C(O)=O)CC1 QMYNQWVHQFVSKA-MGCOHNPYSA-N 0.000 description 1
- JXCLONSFCOTIJC-HAQNSBGRSA-N C1C[C@@H](C(=O)OCC)CC[C@@H]1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 Chemical compound C1C[C@@H](C(=O)OCC)CC[C@@H]1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 JXCLONSFCOTIJC-HAQNSBGRSA-N 0.000 description 1
- QWEWPBRDYZVGBR-WCTZXXKLSA-N CC[C@@H]1C[C@@H](O)[C@H](O)[C@@H](CO)N1 Chemical compound CC[C@@H]1C[C@@H](O)[C@H](O)[C@@H](CO)N1 QWEWPBRDYZVGBR-WCTZXXKLSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000004173 Cathepsin G Human genes 0.000 description 1
- 108090000617 Cathepsin G Proteins 0.000 description 1
- BEMBINBUNAFRRS-AWLKUTLJSA-N Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N[C@H]1CC[C@H](C(O)=O)CC1 Chemical compound Cl.C1=C2C(NC(=N)N)=NC=C(Cl)C2=CC=C1S(=O)(=O)N[C@H]1CC[C@H](C(O)=O)CC1 BEMBINBUNAFRRS-AWLKUTLJSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 description 1
- HVVNJUAVDAZWCB-RXMQYKEDSA-N D-prolinol Chemical compound OC[C@H]1CCCN1 HVVNJUAVDAZWCB-RXMQYKEDSA-N 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000801481 Homo sapiens Tissue-type plasminogen activator Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- IILDQBBNCMYHPD-UHFFFAOYSA-N Hydron;pyridin-3-yl 4-chlorobenzoate;chloride Chemical compound Cl.C1=CC(Cl)=CC=C1C(=O)OC1=CC=CN=C1 IILDQBBNCMYHPD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 102100039419 Plasminogen activator inhibitor 2 Human genes 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 229940124639 Selective inhibitor Drugs 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- FDMCEXDXULPJPG-UHFFFAOYSA-N [1-[(2-methylpropan-2-yl)oxy]-1-oxo-3-phenylpropan-2-yl]azanium;chloride Chemical compound Cl.CC(C)(C)OC(=O)C(N)CC1=CC=CC=C1 FDMCEXDXULPJPG-UHFFFAOYSA-N 0.000 description 1
- RFUWRXIYTQGFGA-UHFFFAOYSA-N [4-methyl-1-[(2-methylpropan-2-yl)oxy]-1-oxopentan-2-yl]azanium;chloride Chemical compound Cl.CC(C)CC(N)C(=O)OC(C)(C)C RFUWRXIYTQGFGA-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N alpha-isobutyric acid Natural products CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-UHFFFAOYSA-N alpha-phenylglycine Chemical compound OC(=O)C(N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- KRRGYDUZFDKPIB-UHFFFAOYSA-N amino 4-methoxybenzoate Chemical compound COC1=CC=C(C(=O)ON)C=C1 KRRGYDUZFDKPIB-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- AXNJKYLFCKEIHI-UHFFFAOYSA-N amino(cyclopentyl)methanol Chemical compound NC(O)C1CCCC1 AXNJKYLFCKEIHI-UHFFFAOYSA-N 0.000 description 1
- AOPRFYAPABFRPU-UHFFFAOYSA-N amino(imino)methanesulfonic acid Chemical compound NC(=N)S(O)(=O)=O AOPRFYAPABFRPU-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001567 anti-fibrinolytic effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- CGAMNSKIHXUDMK-UHFFFAOYSA-N benzyl n-[methylsulfanyl(phenylmethoxycarbonylamino)methylidene]carbamate Chemical compound C=1C=CC=CC=1COC(=O)N=C(SC)NC(=O)OCC1=CC=CC=C1 CGAMNSKIHXUDMK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M bisulphate group Chemical group S([O-])(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- UUWSLBWDFJMSFP-UHFFFAOYSA-N bromomethylcyclohexane Chemical compound BrCC1CCCCC1 UUWSLBWDFJMSFP-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000012822 chemical development Methods 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 108010074800 chromozym PL Proteins 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 150000001925 cycloalkenes Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
- 125000000950 dibromo group Chemical group Br* 0.000 description 1
- USPLDBATMHXKKD-UHFFFAOYSA-N dichloromethane;pentane Chemical compound ClCCl.CCCCC USPLDBATMHXKKD-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- FNQUQCZVFWNFEE-MRXNPFEDSA-N ditert-butyl (2r)-2-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]butanedioate Chemical compound ClC1=CN=C(Cl)C2=CC(S(=O)(=O)N[C@H](CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C)=CC=C21 FNQUQCZVFWNFEE-MRXNPFEDSA-N 0.000 description 1
- FNCGNFXGKHSMKJ-MRVPVSSYSA-N ditert-butyl (2r)-2-aminobutanedioate Chemical compound CC(C)(C)OC(=O)C[C@@H](N)C(=O)OC(C)(C)C FNCGNFXGKHSMKJ-MRVPVSSYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical class CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- XMQSOBPCWYVZSW-WLYNEOFISA-N ethyl (1r,2s)-2-aminocyclohexane-1-carboxylate;hydron;chloride Chemical compound Cl.CCOC(=O)[C@@H]1CCCC[C@@H]1N XMQSOBPCWYVZSW-WLYNEOFISA-N 0.000 description 1
- BBUDXRABCMOOQD-UHFFFAOYSA-N ethyl 1-[(1,4-dichloroisoquinolin-7-yl)sulfonyl-[2-(dimethylamino)ethyl]amino]cyclopentane-1-carboxylate;hydrochloride Chemical compound Cl.C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)N(CCN(C)C)C1(C(=O)OCC)CCCC1 BBUDXRABCMOOQD-UHFFFAOYSA-N 0.000 description 1
- BWYPVQZAFLNQMK-UHFFFAOYSA-N ethyl 1-[(1,4-dichloroisoquinolin-7-yl)sulfonyl-[2-(oxan-2-yloxy)ethyl]amino]cyclopentane-1-carboxylate Chemical compound C1CCCOC1OCCN(S(=O)(=O)C=1C=C2C(Cl)=NC=C(Cl)C2=CC=1)C1(C(=O)OCC)CCCC1 BWYPVQZAFLNQMK-UHFFFAOYSA-N 0.000 description 1
- OSRRNIODAMHKTI-UHFFFAOYSA-N ethyl 1-[(1,4-dichloroisoquinolin-7-yl)sulfonyl-methylamino]cyclopentane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)N(C)C1(C(=O)OCC)CCCC1 OSRRNIODAMHKTI-UHFFFAOYSA-N 0.000 description 1
- HBQARTMVOKXCLT-UHFFFAOYSA-N ethyl 1-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]cyclobutane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)NC1(C(=O)OCC)CCC1 HBQARTMVOKXCLT-UHFFFAOYSA-N 0.000 description 1
- ZGZJPUJUIYKVCA-UHFFFAOYSA-N ethyl 1-[[1,4-dichloro-1-(diaminomethylideneamino)-2h-isoquinolin-7-yl]sulfonylamino]cyclopentane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CNC(Cl)(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)OCC)CCCC1 ZGZJPUJUIYKVCA-UHFFFAOYSA-N 0.000 description 1
- SOJJLUOGEIHGRZ-UHFFFAOYSA-N ethyl 1-aminocyclobutane-1-carboxylate Chemical compound CCOC(=O)C1(N)CCC1 SOJJLUOGEIHGRZ-UHFFFAOYSA-N 0.000 description 1
- NCSBNXBVEDFAHP-UHFFFAOYSA-N ethyl 2-[[3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarbonyl]amino]-4-methyl-5-(phenylcarbamoyl)thiophene-3-carboxylate Chemical compound CCOC(=O)C=1C(C)=C(C(=O)NC=2C=CC=CC=2)SC=1NC(=O)C1C(C=C(Cl)Cl)C1(C)C NCSBNXBVEDFAHP-UHFFFAOYSA-N 0.000 description 1
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 125000001145 hydrido group Chemical group *[H] 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical class I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 150000002463 imidates Chemical class 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940030980 inova Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- AWJUIBRHMBBTKR-UHFFFAOYSA-N iso-quinoline Natural products C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 1
- VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical compound C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 description 1
- MIGRFORREVIOBF-UHFFFAOYSA-N isoquinoline-1-sulfonyl chloride Chemical compound C1=CC=C2C(S(=O)(=O)Cl)=NC=CC2=C1 MIGRFORREVIOBF-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000006138 lithiation reaction Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- DWKPPFQULDPWHX-GSVOUGTGSA-N methyl (2r)-2-aminopropanoate Chemical compound COC(=O)[C@@H](C)N DWKPPFQULDPWHX-GSVOUGTGSA-N 0.000 description 1
- IVBIJYKIVLHYGH-UHFFFAOYSA-N methyl 1-[(1,4-dichloroisoquinolin-7-yl)methylamino]cyclopentane-1-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1CNC1(C(=O)OC)CCCC1 IVBIJYKIVLHYGH-UHFFFAOYSA-N 0.000 description 1
- OVVPFKJIPAJBLY-UHFFFAOYSA-N methyl 2-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]-2-methylpropanoate Chemical compound ClC1=CN=C(Cl)C2=CC(S(=O)(=O)NC(C)(C)C(=O)OC)=CC=C21 OVVPFKJIPAJBLY-UHFFFAOYSA-N 0.000 description 1
- HMZHEECHJWHZJX-UHFFFAOYSA-N methyl 2-amino-2-methylpropanoate Chemical compound COC(=O)C(C)(C)N HMZHEECHJWHZJX-UHFFFAOYSA-N 0.000 description 1
- QVDWKLDUBSJEOG-UHFFFAOYSA-N methyl 3-amino-4-methoxybenzoate Chemical compound COC(=O)C1=CC=C(OC)C(N)=C1 QVDWKLDUBSJEOG-UHFFFAOYSA-N 0.000 description 1
- KJPRUWPBWYKZGX-UHFFFAOYSA-N methyl 4-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]-1-methylpiperidine-4-carboxylate Chemical compound C=1C=C2C(Cl)=CN=C(Cl)C2=CC=1S(=O)(=O)NC1(C(=O)OC)CCN(C)CC1 KJPRUWPBWYKZGX-UHFFFAOYSA-N 0.000 description 1
- GLIKYKRDYKKEBJ-UHFFFAOYSA-N methyl n'-nitrocarbamimidate Chemical compound CO\C(N)=N/[N+]([O-])=O GLIKYKRDYKKEBJ-UHFFFAOYSA-N 0.000 description 1
- FLZZNZJENFNFOJ-UHFFFAOYSA-N methyl n'-nitrocarbamimidothioate Chemical compound CSC(N)=N[N+]([O-])=O FLZZNZJENFNFOJ-UHFFFAOYSA-N 0.000 description 1
- OACFPIYXXBEUPI-UHFFFAOYSA-N methylsulfanyl carbamimidothioate Chemical compound CSSC(N)=N OACFPIYXXBEUPI-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 1
- XLMGLSNJRPCITN-UHFFFAOYSA-N n-(2-aminoethyl)-1-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]cyclopentane-1-carboxamide;dihydrochloride Chemical compound Cl.Cl.C=1C=C2C(Cl)=CN=C(NC(N)=N)C2=CC=1S(=O)(=O)NC1(C(=O)NCCN)CCCC1 XLMGLSNJRPCITN-UHFFFAOYSA-N 0.000 description 1
- PEHDMKYTTRTXSH-UHFFFAOYSA-N n-[6-amino-1-(4-nitroanilino)-1-oxohexan-2-yl]-1-[2-[(4-methylphenyl)sulfonylamino]acetyl]pyrrolidine-2-carboxamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NCC(=O)N1C(C(=O)NC(CCCCN)C(=O)NC=2C=CC(=CC=2)[N+]([O-])=O)CCC1 PEHDMKYTTRTXSH-UHFFFAOYSA-N 0.000 description 1
- CMRGKYASWFPKOB-UHFFFAOYSA-N n-[7-(4-chlorophenyl)-5-oxo-6,7-dihydro-1h-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-4-methoxybenzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NC1=NC2=NC(=O)CC(C=3C=CC(Cl)=CC=3)N2N1 CMRGKYASWFPKOB-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- UCQFSGCWHRTMGG-UHFFFAOYSA-N pyrazole-1-carboximidamide Chemical compound NC(=N)N1C=CC=N1 UCQFSGCWHRTMGG-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- HIFJUMGIHIZEPX-UHFFFAOYSA-N sulfuric acid;sulfur trioxide Chemical compound O=S(=O)=O.OS(O)(=O)=O HIFJUMGIHIZEPX-UHFFFAOYSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
- DWKALJMROLTJPM-RJUBDTSPSA-N tert-butyl (1r,2s)-2-aminocyclohexane-1-carboxylate;hydrochloride Chemical compound Cl.CC(C)(C)OC(=O)[C@@H]1CCCC[C@@H]1N DWKALJMROLTJPM-RJUBDTSPSA-N 0.000 description 1
- VNLZBZBMFYNBFI-MRXNPFEDSA-N tert-butyl (2r)-1-(1,4-dichloroisoquinolin-7-yl)sulfonylpiperidine-2-carboxylate Chemical compound CC(C)(C)OC(=O)[C@H]1CCCCN1S(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 VNLZBZBMFYNBFI-MRXNPFEDSA-N 0.000 description 1
- RJBVJBGFJIHJSZ-SSDOTTSWSA-N tert-butyl (2r)-2-amino-3-methylbutanoate Chemical compound CC(C)[C@@H](N)C(=O)OC(C)(C)C RJBVJBGFJIHJSZ-SSDOTTSWSA-N 0.000 description 1
- IUUYANMOEMBTBV-OGFXRTJISA-N tert-butyl (2r)-pyrrolidine-2-carboxylate;hydrochloride Chemical compound Cl.CC(C)(C)OC(=O)[C@H]1CCCN1 IUUYANMOEMBTBV-OGFXRTJISA-N 0.000 description 1
- NNPRSJWMOALALA-HNNXBMFYSA-N tert-butyl (2s)-1-(1,4-dichloroisoquinolin-7-yl)sulfonylpyrrolidine-2-carboxylate Chemical compound CC(C)(C)OC(=O)[C@@H]1CCCN1S(=O)(=O)C1=CC=C(C(Cl)=CN=C2Cl)C2=C1 NNPRSJWMOALALA-HNNXBMFYSA-N 0.000 description 1
- ZACSMTDYVYATGT-NSHDSACASA-N tert-butyl (2s)-2-(benzylamino)propanoate Chemical compound CC(C)(C)OC(=O)[C@H](C)NCC1=CC=CC=C1 ZACSMTDYVYATGT-NSHDSACASA-N 0.000 description 1
- RJBVJBGFJIHJSZ-ZETCQYMHSA-N tert-butyl (2s)-2-amino-3-methylbutanoate Chemical compound CC(C)[C@H](N)C(=O)OC(C)(C)C RJBVJBGFJIHJSZ-ZETCQYMHSA-N 0.000 description 1
- QOISWWBTZMFUEL-NSHDSACASA-N tert-butyl (2s)-2-amino-3-phenylpropanoate Chemical compound CC(C)(C)OC(=O)[C@@H](N)CC1=CC=CC=C1 QOISWWBTZMFUEL-NSHDSACASA-N 0.000 description 1
- IUUYANMOEMBTBV-FJXQXJEOSA-N tert-butyl (2s)-pyrrolidine-2-carboxylate;hydron;chloride Chemical compound Cl.CC(C)(C)OC(=O)[C@@H]1CCCN1 IUUYANMOEMBTBV-FJXQXJEOSA-N 0.000 description 1
- UPIWJJPDQGQPNO-UHFFFAOYSA-N tert-butyl 2-(benzylamino)acetate;hydrochloride Chemical compound [Cl-].CC(C)(C)OC(=O)C[NH2+]CC1=CC=CC=C1 UPIWJJPDQGQPNO-UHFFFAOYSA-N 0.000 description 1
- RNLQHMIDSCYLAK-UHFFFAOYSA-N tert-butyl 2-(methylamino)acetate;hydron;chloride Chemical compound Cl.CNCC(=O)OC(C)(C)C RNLQHMIDSCYLAK-UHFFFAOYSA-N 0.000 description 1
- CCUFGLFAWWXSKW-UHFFFAOYSA-N tert-butyl 2-[[4-chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]benzoate Chemical compound CC(C)(C)OC(=O)C1=CC=CC=C1NS(=O)(=O)C1=CC=C(C(Cl)=CN=C2NC(N)=N)C2=C1 CCUFGLFAWWXSKW-UHFFFAOYSA-N 0.000 description 1
- RDWZQVGVBTYCBD-UHFFFAOYSA-N tert-butyl 2-amino-3-[(2-methylpropan-2-yl)oxy]propanoate;hydrochloride Chemical compound Cl.CC(C)(C)OCC(N)C(=O)OC(C)(C)C RDWZQVGVBTYCBD-UHFFFAOYSA-N 0.000 description 1
- AUIVQIHTTVPKFS-UHFFFAOYSA-N tert-butyl 2-amino-3-methylbutanoate;hydron;chloride Chemical compound Cl.CC(C)C(N)C(=O)OC(C)(C)C AUIVQIHTTVPKFS-UHFFFAOYSA-N 0.000 description 1
- YBTDADHCDXWFLF-UHFFFAOYSA-N tert-butyl 3-[(1,4-dichloroisoquinolin-7-yl)sulfonylamino]benzoate Chemical compound CC(C)(C)OC(=O)C1=CC=CC(NS(=O)(=O)C=2C=C3C(Cl)=NC=C(Cl)C3=CC=2)=C1 YBTDADHCDXWFLF-UHFFFAOYSA-N 0.000 description 1
- XRNHHAKVBNYKLY-UHFFFAOYSA-N tert-butyl n-(2-aminoethyl)carbamoperoxoate Chemical compound CC(C)(C)OOC(=O)NCCN XRNHHAKVBNYKLY-UHFFFAOYSA-N 0.000 description 1
- CSOJECDGWHHWRS-UHFFFAOYSA-N tert-butyl n-[(2-methylpropan-2-yl)oxycarbonylcarbamothioyl]carbamate Chemical compound CC(C)(C)OC(=O)NC(=S)NC(=O)OC(C)(C)C CSOJECDGWHHWRS-UHFFFAOYSA-N 0.000 description 1
- IUUYANMOEMBTBV-UHFFFAOYSA-N tert-butyl pyrrolidin-1-ium-2-carboxylate;chloride Chemical compound Cl.CC(C)(C)OC(=O)C1CCCN1 IUUYANMOEMBTBV-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- FYOWZTWVYZOZSI-UHFFFAOYSA-N thiourea dioxide Chemical compound NC(=N)S(O)=O FYOWZTWVYZOZSI-UHFFFAOYSA-N 0.000 description 1
- 230000002885 thrombogenetic effect Effects 0.000 description 1
- 229960000187 tissue plasminogen activator Drugs 0.000 description 1
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 108010065822 urokinase inhibitor Proteins 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9816228.2A GB9816228D0 (en) | 1998-07-24 | 1998-07-24 | Isoquinolines |
GBGB9908829.6A GB9908829D0 (en) | 1998-07-24 | 1999-04-16 | Isoquinolines |
PCT/IB1999/001289 WO2000005214A2 (en) | 1998-07-24 | 1999-07-15 | Isoquinolines as urokinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20010059A2 true HRP20010059A2 (en) | 2002-02-28 |
Family
ID=10836172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20010059A HRP20010059A2 (en) | 1998-07-24 | 2001-01-23 | Isoquinolines as urokinase inhibitors |
Country Status (39)
Country | Link |
---|---|
EP (1) | EP1077945B1 (pt) |
JP (1) | JP2002521367A (pt) |
KR (1) | KR20010083137A (pt) |
CN (1) | CN1318059A (pt) |
AR (1) | AR018960A1 (pt) |
AT (1) | ATE230730T1 (pt) |
AU (1) | AU745545B2 (pt) |
BG (1) | BG105252A (pt) |
BR (1) | BR9912374A (pt) |
CA (1) | CA2337247A1 (pt) |
CO (1) | CO5080787A1 (pt) |
DE (1) | DE69904814T2 (pt) |
DK (1) | DK1077945T3 (pt) |
DZ (1) | DZ2852A1 (pt) |
EA (1) | EA200100073A1 (pt) |
EE (1) | EE200100049A (pt) |
ES (1) | ES2189434T3 (pt) |
GB (2) | GB9816228D0 (pt) |
GT (1) | GT199900116A (pt) |
HK (1) | HK1040996A1 (pt) |
HN (1) | HN1999000116A (pt) |
HR (1) | HRP20010059A2 (pt) |
HU (1) | HUP0103665A3 (pt) |
ID (1) | ID26993A (pt) |
IS (1) | IS5789A (pt) |
MA (1) | MA26664A1 (pt) |
NO (1) | NO20010400L (pt) |
OA (1) | OA11578A (pt) |
PA (1) | PA8478901A1 (pt) |
PE (1) | PE20000937A1 (pt) |
PL (1) | PL346022A1 (pt) |
PT (1) | PT1077945E (pt) |
SI (1) | SI1077945T1 (pt) |
SK (1) | SK1062001A3 (pt) |
TN (1) | TNSN99149A1 (pt) |
TR (1) | TR200100222T2 (pt) |
TW (1) | TW530049B (pt) |
UY (1) | UY25663A1 (pt) |
ZA (1) | ZA200100230B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003219039A1 (en) * | 2002-03-11 | 2003-09-22 | Curacyte Ag | Urokinase inhibitors, production and use thereof |
KR20060111524A (ko) | 2003-12-02 | 2006-10-27 | 쉬바르츠파르마에이지 | 펩타이드 화합물들의 중추 신경병증성 통증 치료를 위한신규한 용도 |
EP1604655A1 (en) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in trigeminal neuralgia |
EP1604656A1 (en) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS) |
EA027836B1 (ru) | 2006-06-15 | 2017-09-29 | ЮСиБи ФАРМА ГМБХ | Фармацевтическая комбинация для профилактики, облегчения и/или лечения приступов эпилепсии и ее применение |
-
1998
- 1998-07-24 GB GBGB9816228.2A patent/GB9816228D0/en not_active Ceased
-
1999
- 1999-04-16 GB GBGB9908829.6A patent/GB9908829D0/en not_active Ceased
- 1999-07-15 EE EEP200100049A patent/EE200100049A/xx unknown
- 1999-07-15 DK DK99928177T patent/DK1077945T3/da active
- 1999-07-15 KR KR1020017000956A patent/KR20010083137A/ko not_active Application Discontinuation
- 1999-07-15 PL PL99346022A patent/PL346022A1/xx not_active Application Discontinuation
- 1999-07-15 EA EA200100073A patent/EA200100073A1/ru unknown
- 1999-07-15 PT PT99928177T patent/PT1077945E/pt unknown
- 1999-07-15 AT AT99928177T patent/ATE230730T1/de not_active IP Right Cessation
- 1999-07-15 BR BR9912374-6A patent/BR9912374A/pt not_active IP Right Cessation
- 1999-07-15 OA OA1200100002A patent/OA11578A/en unknown
- 1999-07-15 AU AU45289/99A patent/AU745545B2/en not_active Ceased
- 1999-07-15 SI SI9930178T patent/SI1077945T1/xx unknown
- 1999-07-15 ID IDW20010169D patent/ID26993A/id unknown
- 1999-07-15 ES ES99928177T patent/ES2189434T3/es not_active Expired - Lifetime
- 1999-07-15 EP EP99928177A patent/EP1077945B1/en not_active Expired - Lifetime
- 1999-07-15 CN CN99809025A patent/CN1318059A/zh active Pending
- 1999-07-15 DE DE69904814T patent/DE69904814T2/de not_active Expired - Fee Related
- 1999-07-15 CA CA002337247A patent/CA2337247A1/en not_active Abandoned
- 1999-07-15 HU HU0103665A patent/HUP0103665A3/hu unknown
- 1999-07-15 JP JP2000561170A patent/JP2002521367A/ja active Pending
- 1999-07-15 TR TR2001/00222T patent/TR200100222T2/xx unknown
- 1999-07-15 SK SK106-2001A patent/SK1062001A3/sk unknown
- 1999-07-16 HN HN1999000116A patent/HN1999000116A/es unknown
- 1999-07-21 MA MA25695A patent/MA26664A1/fr unknown
- 1999-07-21 TN TNTNSN99149A patent/TNSN99149A1/fr unknown
- 1999-07-21 DZ DZ990152A patent/DZ2852A1/xx active
- 1999-07-21 PE PE1999000733A patent/PE20000937A1/es not_active Application Discontinuation
- 1999-07-22 AR ARP990103614A patent/AR018960A1/es not_active Application Discontinuation
- 1999-07-23 PA PA19998478901A patent/PA8478901A1/es unknown
- 1999-07-23 GT GT199900116A patent/GT199900116A/es unknown
- 1999-07-23 TW TW088112548A patent/TW530049B/zh active
- 1999-07-26 CO CO99047012A patent/CO5080787A1/es unknown
- 1999-08-16 UY UY25663A patent/UY25663A1/es unknown
-
2000
- 2000-12-22 IS IS5789A patent/IS5789A/is unknown
-
2001
- 2001-01-09 ZA ZA200100230A patent/ZA200100230B/en unknown
- 2001-01-23 HR HR20010059A patent/HRP20010059A2/hr not_active Application Discontinuation
- 2001-01-23 NO NO20010400A patent/NO20010400L/no not_active Application Discontinuation
- 2001-02-14 BG BG105252A patent/BG105252A/xx unknown
-
2002
- 2002-04-10 HK HK02102712.1A patent/HK1040996A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6093731A (en) | Isoquinolines | |
AU6273696A (en) | Arylsulfonylaminobenzene derivatives and the use thereof as factor xa inhibitors | |
ES2221829T3 (es) | 2-piridinilguanidina como inhibidores de uroquinasa. | |
CN102264737A (zh) | 抗病毒化合物 | |
CZ258496A3 (en) | Antithrombotic preparations | |
MXPA04005862A (es) | Compuestos antagonistas selectivos de pirimidina a2b, su sintesis y uso. | |
JP2003500376A (ja) | Xa因子の阻害剤 | |
JP2010507674A (ja) | マトリクスメタロプロテアーゼ阻害剤としての三環式化合物 | |
WO2001012600A1 (en) | INHIBITORS OF FACTOR Xa | |
EP0927035A1 (en) | Thrombin inhibitors | |
JP3600794B2 (ja) | ウロキナーゼ阻害薬としてのイソキノリン類 | |
KR100403687B1 (ko) | 관절염질환및골다공증치료에유용한브릿지된인돌 | |
HRP20000788A2 (en) | Novel heterocyclically substituted amides with cysteine protease-inhibiting effect | |
JP2000503010A (ja) | アミジノプロテアーゼ阻害剤 | |
AU2277699A (en) | Matrix metalloprotease inhibitors | |
HRP20010059A2 (en) | Isoquinolines as urokinase inhibitors | |
JP2007501267A (ja) | 新規イミダゾール誘導体、その製造法及びその医薬としての使用 | |
MXPA00004241A (es) | Nuevos compuestos de 2,3-metano-amino acido, un proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
CZ2001289A3 (cs) | Isochinoliny jako inhibitory urokinasy | |
ES2266806T3 (es) | Derivados de piridazina, su utilizacion como medicamentos y su procedimiento de preparacion. | |
MXPA01000888A (en) | Isoquinolines as urokinase inhibitors | |
CZ20001340A3 (cs) | Isochinoliny jako inhibitory urokinázy | |
MXPA00003715A (es) | Isoquinolinas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
OBST | Application withdrawn |